var title_f8_20_8512="White centered RH";
var content_f8_20_8512=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    White-centered retinal hemorrhages",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White-centered hemorrhages appear to be caused by fibrin plugs, ischemia, or central resolution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Brian Forbes, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8512=[""].join("\n");
var outline_f8_20_8512=null;
var title_f8_20_8513="Advancing bladder off cervix";
var content_f8_20_8513=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Advancement of the anterior portion of the vaginal mucosa during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blunt or sharp dissection may be used to advance the bladder away from the cervix.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8513=[""].join("\n");
var outline_f8_20_8513=null;
var title_f8_20_8514="Hymen anatomic variations";
var content_f8_20_8514=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anatomic variations of the normal hymen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 235px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADrAb8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACio2niWdYWkUSspcITyVBAJ+mSPzrGufFej29+bVryNzGC1xKrAxWwGR+9fO1SSMBc5J7YBIAN2iuQ1PxGmoJBBo17bvaalbK1tfQSg7i0yRsUbpkB8j3rrwMAD0oAKKKKACiiigAooooAKKiu2mS1ma2RXnCExqxwGbHAP41i6B4p0/V7QzFxaODgx3Dqrf6sSE9egU8+mDnpQBv0VC11AkscckyI8jbI1c7S5xnC5+9xzx71Q8T3sdjot0zuVkkjeOIK21ncqSApwecAnoelAGrRTIY1hhjjXO1FCjPoKfQAUUUUAFFFFABRRRQACiuZ8VeJH0DU7FZIhLZzW80kgHDhkeIDBzjG13J+ldFPcQ267p5Y4l4GXYKOenWgCSiszxFcPa6as0c/kbbiAM+AcqZUDD8QSPxrToAKKKKACiiigAooooAKKKwPFGvp4ektLi8/wCQe6yrIVXLB1XeuOf7qv8ApQBv0VFaXEN5aw3NrIssEyCSORDkMpGQQfTFUvEuoSaVoN7fQosk0MZMaPwGboAfbJFAGlRRRQAUUUUAFFFFABRRRQAUVkvc3MPiiC1ZlNlcWjui7eUkjdcnPoRIOP8AZ96r3fjDw7Z3DQ3Os2MboxR8yjajDqGbop9iRQBvUVk6lfsYNNn0+4je3nuY1aRMOrxtnoenJxzWtQAUUUUAFAoooAKKKKACiiigDz/4wAyaVax3Mcn9mBjLdSxKS6YKqu0jjOXJwe4HpUl1o0ej/Di7kns4p9Q2vqVwZLZLgm5b5nfYzKpIyQMkAADsKteMrpH8S+HtLEjGW5cs0OzIZFdHJJ7YCH68+lc18fPG2jaDpNloOpuJJdXlRZYBJsxbBgXLt/CrY2Z/2j6GkBl+GtFSHXdPmO7S442W9ZZbL7EH+ZNyMisYTncjbkwcrhs8V7XXj3wt0zR/EPg3TrzTUsYPLe4tr1Ek3iVcPGpJB+8cRtuHXB5z09S0O/GpabFcbdkvMc0feORTtdT9CDQBfooopgFFFFABRRRQAV4rdxXMHi/UdMsEtJ7w3+2C2uIyY2WSOdm3juircZPqEC9SK9qrj7bTDF8Trm8lZX82zaSIBP8AV/6pDk+vyH8DQBh+JbBPDtrpkEniZ7FSXZpn083lxcztgO5OG2AhgMKBjOAQMCuR1HTdUstCt7mTxIdX0h5EWzjlEiyLgSLI2JCX4ZgOSSOOcYFdd8Y/FmmaX/Z+i3+tNpZuibmeSFysvlJwqrtBYb5Si5XBwHIIxmuf1SRfFnwz8Pa9olrcXMf2d7eaGKR7qWJmdC2CSWfEkW3qThs9BSGe2UVl+F746hoVpNKf9IVfKnBGCsqHa4x2+YGtSmIKKKKACiiigAooooA82+L7/abG2hs1U3/nPYxb1OGklhJVeOcEhc//AFqs+IPDMNl4cn8yManrF/NGbi5n05b5pnBJA8tiFVF5CjICj3OTBFBFq/jm0d41dYtVur5dw/54W6WwI/4G5/KqXx4s5Ly00IWxluLmO6aRNPjj3+eqgNI+C6j5Iw+Cc5LBcfNSGUNQ8b3k9rcaFfWmLuNpHcSWxgIiWLzY8IWOPmUrnJBCe9exKwZQy8gjIrxzWGh029+H9pZPb3FheW88cWo7eWLiPaApzwVZiOeMdhXqXhq6e98PabcS58yS3jZ8/wB7aM/rmhAaVFFFMQUUUUAFFFFABXnfx8KRfDa9unm8k200Ugk9MuEb/wAddq9Erzz4yWq6zZaDoDkCPUNTgaYZ5MSOGYfjx+GaANPwfc3kHhW1EUVvDYxrBbaebtzG80QCr5j4B2s3VUxnpnBOByPic6ouqpf6pHPaee8dhcWwdpYA6yJIJYmOBtdI8dAQQQeTzqfGZL1rLTBaWtvOPtMaxK15cQuz7tzYWIjhURm3EkjHyjNOu01a68DWRtHW4s5bacF4rlrkSxmEyQzb5AH++qjByfm6mkM9IoqCxuEvLK3uYjmOaNZFPsRkfzqemIKRhnHJGDnilooAKKKKACiiigDyz476xqXh+38M6rpk0sSQ6j5c5jBOVeNlAI6HLEceuMVsWGq2Ph/S4bXxTfWmn3E+2dNOtEKx2kechfkGduQdzNwTuHTioPiXbSal4u8A6ekwWNtSe7miyf3iQxl+3GA2zr61P8Q4bOPU7C7SynutbEMslqY5CPKWFfMYhehLHanI/iHakBqNpstrHeQQ29o+jK8V3Zxw4iMbh97qf4du4Bwf9oj0rp65DxVdx6n4X0nVtOnb7K1xbXCyI3WOQ7M+nAkz6cV0WiXYv9IsrpST50Kuc9ckc5980AXaKKKYBRRRQAUUUUAFFFRpIXlkTY4CYG4jhsjtQB5brniWztfGeta/dIz2Hhy0MWUABkmY7VQEnGSzOv1FcrFbrq2lJqZtry/8S38xub25+wSTC3+XasEUscbKY17AP15OSTXQ+KNCtf8AhJbDw7pdnqV1aRyjVLqC3faHkI2QxvMfuINsshydxIGMk12v2S08PatZxaVo9xJJdRSLJetIzRwKuDiR2JPJ6f7p/FAeZQaFceHRJrV7CYtHv4PI1OQuEZYy+FnMTRI6vG7A5Jb5S3tXpXhq5WO6lu7meOCW6dbW6t3OM3iDG5O2HQA+4Cn1pLOGa/kkk1C9t/EGl303lCGCNDDaqUO9X+bEqblA5G4FvTpzWhaLItxq+gzahHFLBGq2tztALhZCbaQc8vEQ0TDPIRPWgD1OiobSdLiAPHLHLglGaM/LuUkMPwIIx7VNTAKKKKACiiigArk9U8TWWn2V9rAsXmnWf+zbQKQHvZA2AiZ6DeXGT0Cs3QVr+J9SfS9FnmtwGvHxDaxn+OZztQfmRn2BNeY+I/D95rHiTSfDthPaGw0axMU/2qYr588qfN8qjcx8sMTgr/rDzzQB5j4xFl4l1Nb+602bxDqDn/SpjJcRRRsMgJCkTZWNVyAWwTyT1rf+F+oXPhKB7PUNP/4R3wrrDCCFv7T3SQ3BPliWINhgvCq2c4JU9Ca9e03SYPDVxYxaBpdlcXTq0N7LHO6eXtQMAqtvwC20YLcBgeaxvEfh/VNTF5NrVtFcy3Eqx2sC6pLBF5bAAxMArru+98wQBhjODzSsB0Oh6veWt9Y6frVglrLdLIhuVGFnuUPPAGPnQb1+jDqK6yvJ/DPimH+x7zR9dghurvQblHdY7wXDR2yyfLNvABZ4sYfgH5cn73PpcepQPq0mnEOlwsQnTcPllTOCVPfBwD6ZHqKYF2iiigAooooAKgv/ALT9huPsHlfa/LbyfOJ2b8cbsc4z1xU9cvc6/LD4b1DUYXS4lkuZLewjGMO+/wAqNffLjP0J9KAOP8DNb2moa/4n1K5mg0zRIptJWW4XYsqRFXmnx1BaUSfXIHavLvFN1L8RNdXULzVdT09p9sNjZ6e1vIIoSwZNxMoXezBGYHBBAGeK9S8VWFzeSad4T0+G6v4dNhS+1IW0kaNNM7Hytxk+UAuJJTkH7i8HNdZBcWvhe8sdNig1e6kvjl5pZnnWLHHLO2M/7CDOATgAE0hnlPhrQtVbQD4IlmuF1vRib7Q77U4BDuGCrxtsd8lRJ1BPDKcfLivXvBMtwlndWF/CsF1bTbzGrBgFkHmDBHYFmX/gFcdqlrJr3iCHW9P0yLTPEek3JlSCWBFuNRtvuf6wgFQV8wbckZAzxg1t6CdO0jVo9R0qeOTQ9e2rDJuOIp8swQE9EYs+F/hfI/iwAR3NFVrC6F3Cz+VLCyO0bJKm05U4yPUHqCOoIqzTAKKKKACiikZgvLEDJxye9AC1xujTQ6nreseJNQFummWRNpYzTADYsW7zptx+6C5K59I89DXQ+IE1CTSpotIZEvJcRrKx/wBUGIDSD1KjJA7kCvNfGmnLq8sHgfRXjFpp0EJktmuUiNw5+6r7lYsqqpkYBTkshoA84+LXjPUdf1drjS7lNNt7ZfL09rhWBeNsF5yoXcC2FC8j5M5Hz10n7PviOfVfCWo+D72/mW7UTDT9RjiKJIGG51Q4ALRsxO3spHGBXRaLp2heAtSsbCPRrrU/EjxmaRdJ8x/KhLbQ0gklwRk4z7ZwMVY8bx+INfMllBo02mNZXJltLq0vIZLhsZ2ypC+1MnB437gMjoxyhm78JNXe+8Mvpt6yDVdGmawu4lPKFfu8ehXGD3rt64r4eazLrEM8t1pUNjrkcnkasHiMEzFRiKTbgllZeRljgZAJwa3o9Wkj8SSaVeQLEssXnWUytkTBcCRSMcMpIOOcqc9jhiNeiiigAooooAKKKp6tdvZWMk0Nu9zNkJHEmAXYnAGT0GTyewzQBgo9rd+Nb/UboCOHQ7X7Ms8vyorShZJTk8YCLDz2ya+afiH4s8X+MfF97eaE0Npob24trOK4ZCZ4dwYPtGWUswDduAo5r1zxDomq6+H0O3W7urC0nD3/ANnljjS/vHHmOsjuGxDGCowFYklRj5K6jT7bQ/DBTSrmC8nuJrUSm2ZWuYhgHKoxULuOG4wMhc4HFIDyH4D+M9X8PT2ngbx9pt7FZ3jmOxnu7RwokZifKJK4ZHJJU9jweMY9s+Hus2t/FqdhbZT7FdSbInTYyxsxIyvswkT/AIBWL41S68Q+G7WTTrfXrexuI2jkt4bW3Yw7W+VzFIQ+4EZUxt2BweKm+Fiy6g02u3FpDFdXUIhu98XlTRXSMVlG0jKo+1JNpPBJPfNAHoVFZ2h6pHqto8qxSW80UjQzQS43xOp5Bxx0wQRwQQe9aNMAooooAKKKKAKmr3TWWm3FxFH5sqIfLj/vueFX8SQKydRnm/tDT9OhmFukK/bb+SP5QI1Jwue298n/AHUYd6v3TQ6jPJZox8y0lhmk6gfe3Acf7vT6VzOvMX8LalJGXa68QTrZw7l2lVkxEv4Km5/zpAZvhzUlhkn1qJNQ1HWtZU3aabC4Cx27YELSE4VPkReWPUtgE5rpNf0611GwmTW9La4tb2KCK6ghlZ9538KQMZVSSSeNwyCD0qlYaDaaxfXZ1T7JLbWzrCNMt8GJCqjaZ8f6x9u3APyqMYBPNdkAFAAAAHAAoA4nQfDek6VbJoPh3RRZ6SLr7dcq5ePa24OhTuTvUcdAEx0IrE+NE8FhcaNfXANvCjlJ7/zWUwRkr93KlNwbZIBuBzGOCM16hIGZGCNtYggNjOD61znjXRbjVtOcW7TmdI9qJDNs8zPDq6NmORSP4XHryOoAG6bcXzWkF8ZV861VodQsYFDq79S6Y5DHIYDnIbGM4I6G0uYby0hubVxJBMgdHHRlIyDXnHw1ubnTrfT49TMyXLf8Se7SaMIRcQBjE5AJHzxY6E5wnJrttHgnstQ1G1MWLEuLi2cdBvzvT8GBb6OPSmBr0UUUAFFFZPhiczeH7S5lkkbzVM26X72GJYZ+gOKAKzf8THxVudUNnpKZDE/8vDrz/wB8xn/yLVDwBbxXVpc628KtNql1LexSuo3LE2EjAPUAxxxmszVJXTwVDawgwX/iW6MIZVJZPPJLOQP7sQPPYqOlU/G507SdXtpYdUkspIrVbYRw3tna+XGDwu6VfMwcdAccUgN7xrpVhr2n3Oi69NeQ2ty4dJrMyQbSRtVWdT8xyGPpgDI6ZoeFNE0fwzoq+FNEuNRuhKo+03BuXeRN6AGUMchc/KcLgDJIqnJ4k8QarbxxaXollNYvalxc307iJXDYR3cqoYblzhAxPByAQTLp9z4k0uW11jX/ALNcRzAx3h07ThM0ca/d+dZN5XJJGFfHOcZzQBzHxT8V6FpusC+t9OvrjU7HG67UYhdAWSW3beQMMhblQedp5wK7Pw+/2vwxAbFlu7/RW220rtzNCUBjOR1Dwsv/AALr0rxyXxAkWpLNaWkax+cZh9hsTbeYu7IOUkAORnkjnOa7/wCGGt2S61PFYS5smnNmsZwGhVg09urcn7uZ4x7KntQM9Xs7mG8tIbm1kWSCZBJG68hlIyDU1YXhlGsp9T0tiPLt7gywD0hl+YD6BvMUeyit2mIKKKKAMvxNfyabod3cW4DXO0R26no0rkLGPxYiuf0yxij122s5XQaf4cs0ILcbrh1IMh9NqA/jIfStTVh/aPiXTNPAJitP+JhPwcZGUiX/AL6LN/2zrl/FbQ6hALDR715ZfF14LczKMCG2ijxPtP8AuRuAf70gxxSA2/hxA02l3evTqRc65cNfZPUQ4CwL+ESofqTVfWtNvdcsdZs9K1jVNA1Oa5AjvHhQnagxtjB+9HjLZBBBfqORXWj7Np1ki7ora1hQIuSFVFAwBz0GK5fUbWDxHfvqHh/xFFNfWEDRw28cySW8crD5XkCfPnjoGGQCO5ywGaZpF9oWg6Va6xe3nifVIroLFftDFHLAHBQyYJ6IrHJ+YnnrXP6LY/ZNT1rwPqb3zW2oLLfafeXjQCR5dwaUosRGArski5VeS3pXR6F4Y1QXulaj4j1f7Xf2YlZ0gDLCzsNqkAk4CoWB4+YnJ6Crnjmwkk0xdU06Hfq2luLu32jDSBc74s+joWXHqQe1AFGy1eRtPsNbum8qW3Y2GqxKvAcPsLewV/mB/uMTXZVh6Za6Zf293dW8nn2utxLctC5G1lMaruC9RlduferHhm/k1LRLa5uEEc/zRyqucB0Yo2M9sqaANSiiigArB8Ur5txoMG7HmaijY9diPJ/NBW9WBfn7V4z0u3H3bO3lu3/3mxGn6GX8qAGlnvfHAUP/AKNptnllB6yzNxn6JGf++6o/D61guo9S8QtFE11ql5NIk+wb/IVvLiXPXGyNWx71Q1XUprPSfFU1quzUb3UV0+zK4J8xo4oo2+iklj7A1ueFtU8PpZpo2japZ3H9lwJC6RSqxjVPk+bHA5H50gK+vadrupaXqsWkXFho2rzS+RFqHk+c4t+CGxkfPycA8A81j+GtD13QtNsR4t12LxFqxvlME89uIUgDAo4UqO8ZYDdwWIHcVq6p4W0zWtV/tfTZ47bUGVoJ721OZGXynQYIOA678gkHHp0w3QvCMlvfx3es3QvpLcuLcMWbaPM3IxJ6uB19+mKBnNXfhaLwPrba5pEcdppc0qW12tuFj2wSkoMKBj905Rw2ScM/TvsXlzeS+BWv2QXuu+H5Gdlz5ZllgyH5xx5kZPbH7wV2GsafDq2lXmn3YJguoWhfHXDDHHvzXG+CruZr23j1Anz9TsStwGbObq1byZj/AMCBX/vigR3VtL51vFLjbvQNjOcZGevepKpaLDcW+kWcF6Va5iiVJCpyCQMZq7TAKKKKAK0t0EvoLUJuaRWckMBsC45x1OSQOK4zxtqpt5b7U1Q3EWhxYt7dVL+dfygCNdoySVDrjH/PU9xXQaO5vNc1a+OPJiZbKL32ZLn/AL6bb/wCuQEU2o2/h61jiWS6unuddlUSmPnDeWCwBK/NNGAcHGzjpQB0PhbSNO0/QNKunN0GsYJGaWfzISztzLK8Zxyx3NlhkZ4rlvEureI9E0bTtR8NaH/wmc87b5buK4jSIxmT5CqDlm2tt3AYABJr0PQ9JtdG09bSyWQR53MZZnlZmPUs7kkk+prD1Kw1zStNvG0IQXRDtLBYwolqPvhggJBGTl9zHGcjG05NICGSyi1lNIk8Q+Hbdb/UIPKvLN7pZRbIuZAccCTa+0ZAypfjvXD6fpd/oXjHVdA8uKOO+26jpMkUbxxG6gAJX55HLFk2hjwPkPFdb4Z8K6xH4pGr67exyW9tEVs7Zcs4dhtLyueriMKhwSCQTxwK1PiDawppKa4LdXvdFkF7FIF+cIv+tUHrho9wI78UDJLO8hll0/XrRVittRjSG6Ehwytz5ee24MSh78j0rpa5XQI4JrrxBolygkt1uBdRKejQzjeCP+2gl6eldUOnNMQUUUUAFFFUtauLi10u5lsoTPdBcQxju54XPtk8+2aAKGlRS3NlqtxHIY5b2eXy5F+baFHloRnHZN2PesbXb6C18UWzXkyC10m08yMSMQHuZQ6puODj5I5APeTucCt6+VNL0KGCFBhGhgVQB1Z1Xoc+ua5h4oL/AMS6opkmiupdSSGGaG3EjRrHbIWIYgiP/WMNx5+bA5NICPSJda1q4WIjUdDspQ8kjWtnFCokJyfnmJkYkk/MIlzXV6DoyaWZnXUNTvGk4JvbhpMY/ug8D8BUWmabaw27Q6fJLLGkyzCa5la6BYNhtrMxIbgg+hP4UQ64dQuNRttKtpmNqHT7ZKmLczLwUHO5iD12jHBGc8UAWdb0gaqsI+36jZGIkhrOcxbs/wB7sfxrkhdeJ9GZlf7RcQgts+1hLncB0O6ELIo9f3cmKSTV9esrFbj+1bPUozF9vWWOz8lJIUU74x8zkHc0ZJxkLu4JFaST6Z4qlOmeINGSDVoIzMkN0qyDYePMhlX7y5wCQQwyMgZFAHGWGojVdY8SQWqTJdT20erorXAuES6t3AIjbOVBAiBRlQj0Ga9PbWbddO06+wxtb1olV+y+Z9wn2JKj6sK80s4EsPGGlzTCymu7S9W1mntb8TGJJI2j8pw481QWMTbWLrkDBHSuwisGufh9eaWrBpoIp7aMhtxVo2YRnPqNqmgZ11FU9GvV1LR7G+T7tzAkw/4EoP8AWrlMRS1u5Flo1/dMcLDBJIT9FJ/pWXdR/wBk+AZYi7D7LppTf1OVixn3PFW/FWToN1ECoM22DLDI+dgnT/gVQ+LwsmmW9mylheXcMBAOPl3hm/8AHVakBw/j28t4tQtbWS4aP+zoIbeJIpp45ZLic8Iph+YsEiPGQDv5IFcXp9q+r+J4Ee5d5Une3WO/nmaUSjhxHtllk8sfddgyDI2kgBgdLxN4sistd1jYQ11NrPlwOySbYZ44kii+6B5gyWcjJ5G3GTV74d3Nvot9Fbpr8fnXEo+02gs2uruZgAn754/lhOeSmPlJJJJJNAz0iGO2jtbzSJ9IuJ7WGHzZC8fmw3LNlmVd7Esc9j6jmsHw9ceFo74WttoF9oVzcyRzeVJp8lsjvHkqdyDy+OeM898112qavb6bPaRXEd47XL7ENvayTAHj75RSEHPVsCsfVG117u9uNO1vS7axtjiSK905yEwgYkyeauRznIGB07GgRw3jLRnSa58QjVDqOlTodt3FZW939kxkpuTynLxDOCyYYDBIbBIwdLv5jrAiuJIZpxZPJG0EbIRNbN58QZPs8SqNvmjuTuIrudb07R4baHVdGs2h86JjNquiKrxKcc+bCp/eocnPDEY6g81xtjp+paWdB/tidbie1kt7oGPU764jaFpfKZlWQeWcxyHIzkelAz2aztYpdSOsRSsRc2sUSp22hmYN9Tv/AErSrjdStrvS/hzAtxhrzS44ZAQc58l1I/NV/WuypiCiisLxfNM2nxabZymK71KQWqOpG6NCCZHHuEDY98UAZcN+9t4X13xGyhZ7pZJoBjny1BWEfjgN9XNch4inudA1vTrfSZFeTQdJhgitVjDyXE07gbFz0YpbsSQGIUscV3niqJfsWkaTAoSO5vYYdg/55x/vWH02xEfjXL+GtHg8SarPr93BPeafqtzJOiNKEgSOECKEtHjc5cBmAJKgMeM4ygKOn6Jr3jfU7PV/ED6KdPhYxi2t2jmKYPzAna43ZGDhvy6V3OpeDNC1Ap51k0SoMbLW4kt0IznlY2UH8RUmpazYaHs020t998YTJa2ECBDMAQCE6LxkE+gycYrHs5NT/tsW2u6jqbXM0ZAh07T3Szh3gj/XlCWYf3iwGf4R0pgdImlrZ6J/Z2jSfYAiFYXC+b5fOc4Y8/jXjmuTeMPB+ozW2j6vd6zNCiyCCSaOaSYHkjyWkMg7gbcflXQXM8+lXF9af2v4ygsd5Bnm02S6KuPlLRyhT8hXOAykBsMMdDt6a9r468PTxahZW9tqiMVdbmyWRoCCCpKSA8lSOvUHI7UhnGfDvxE994Rt9Z+yyWd3oGpTWt5aTRtC0drM4ZlKEkrtDIwBJ/1WK9lluoIbmC3klRJp93lITy+0ZOPoK8j8F2EMniDxFoL3CNHqWllNnkXMDYRmQt5c5O0ASgDYxU4zgV1V/fPL4P0DXpDm50+aCS4IGSOfJnH4BnP/AAGgDuaKKKYgrB0cNN4p1+5I+WPyLNT/ALqGQ/rN+lb1cPHLMvg7xBfWe7ztQu5zCw64ZxCjj8FVh+FAHLNrFv8A2jDc316ljpyi91iOaTHzySSm3tiAQ2TtJIGDksvBPFT6Z4c1rWWafU9FsLhDzG2uvJKVPqIizfqI/wDdFWrnRoYPic1/FDZmz8P6DDBBFcnGZWeUoFdjtTAT72Cfm7c1z9hqOs69e3F1f3esweGbp3jt7PSLv7QZ2B/eTG72p5UKk7QA4yQcEgYKGeheH/BcVhcC7vLlzcrL5qQ2EktpaR8AYEAkKnpznOfSl8d2d1LYXE819ZjSURTLa3GnyXGSG+8DE4cdugOMZrOvNG028t9N0prTS7nwjaKXFzPqsryh1DEgDndgZJLP0zxxWGt4+j+H7680OPw/N4cW43Q3MXiKRvLZThSPMRow2cHZuC54OaAKYdG05rzwh4mRJ7RFN1YWclzcFGLY3eU3mMq4I4MXrzUfgHVbieye8vLi3nu9P8RL58sBOwpcxqjcEAr88mSpAwR0FM8MeOrm2t9VvptX8Pf2faXCG8ur0BLkGQgYKwbkPRQGUkHvjGBcuYrORvEr6LfX1/Z6tpUl3AbmR32TW0mdqFxu25lTAJI444FAHq8t9FFqNvZPuEs6O8Zx8p27cjPr82cegPpVqsTWI3vrTS9QsVaSWG4inj24yUb5X69tjsfwrbpiCquq3sWm6bdXs/8AqreJpW9wBnH1q1WJ4lZ5JtJsYmK/abxTJjvHGDIw+hKKP+BUAVY/N0PwDPNc8XUNnLdTY/56kM7/APjxNcbZ65PoWt3UrafDNDbR2+jxyzXccO3yoldwoOXdi0vRR/AK7nx5FNP4R1OC1jkklmjEQWNSzfMwUkAdcAk/hXmUWnarrmqX0FjpyyxwateyM8szRxSAzMuHYDgYQDAEhOOQvBpDOh1L4sWomeDQNC1fWZ0yWWGLaB7Ecsp/3lFdV4S8TJ4jhlZbG4spIVTzI55IWZWYHKkI7EEY/iAz2rPsvBujRWVsmuW8E0x2j7O8pNsH9I4jhP8Ax0E1FN4gtvDtzPBa+FL2309HMZuYUtoEkYf3EaRWce4XntmgRZ8S+ItX0Iz3E2maYdMRtsc8uqeSzkjgFWjwCTnjca5qH4qWGoXkVncacEspUKXbm4Wby88cCLflcdS22tLQ/iZaXt6bPV9F1nR7x2xawT2ckrXC/wB9TGrLgZGcnjNHj/8As/Up5LRr2RL+3T5bFtOjuPPzg7o1dQz4BOfKcEYPcUAN8Ei4S38K3eGf/RJdJuz1O6InYxx6GOQc93r0Dcu/ZuG7GcZ5x61w/gRl8NeFtaivd5h0q8uWcoHc7TiYkbizEYfjJJ9zXXNZwTahb6gM+dFE8asp4ZHKkg+vKg0AW6KKKYBWVqCvca5p0GwmCIPcucHG4YVBnp/Exx/s1q1kaUWm1jWJ2wVWSO3Tr0VAx/8AHnagCzfzQ/bLC2kaUSyyF0CdDsUk7v8AZ5H4kVxGmapKmmu9j5DXOoazcMklxOY44lErohfBy24R4VB972AJrotUuFtNevNRm5i03S2kxjpuYs3P0hFc78PtKkhso9Q1ODTUsbeErC7RkzqyqUkYtnCg/vTjk4ftjlAdBrGrT6ZCGgsJYbVWl852McSIq5O9STjc7EBQxHUk4xWXYTDX7JIln+w2jBfsTyhRP9qXLeYsiOUlB5JA9GByCcR+HtQFnqOl6Q1w8unTxiW1SbIltWChkhdx8r/LyBnePlzuByJ/iWpttHt2tSIkjn88RpED5kwYGMIccSGUpgcbgWzQAl9ot5bC+ZYlezj+2zxqrgbvMiX5MHgZcyHk4GBzVbxTaW174P0a2kuxaa9GkbaZKrgSmZQF+Rl3fK4OCRkBWyelcJ4k8Cw2ui+IIby9nudXk0x7pbOK5n/e3cnLzCNZCuN52hfLHQda9G8D68+s3TS2sdvLZSwRs0kd426E7RtVrdlHlkgnlTg4oA57xZOuo+F7LxOipHdWcy70gtBNueOUNkTOivtXYRvGFPPXrXeeGixfWMsCo1CQLgAYG1cj881514ivxaWPjzRdNS1uY133f7y6YmESRMZdqBTswyt6AtJg4PX0vQHVor0CFInW7lV9n8R3cN9SMZoQFnSrCLTNPhs7bd5MQIQN2Gc4+gzirdZHhq6mure9NxL5rR31xEpIAwqyEKPwGBWvTAyPELbm0y3X7017Hx7JmQ/+gUmtjfqehR8Z+1tJyM8CGT/EVFKpu/GcHGY9PtGc/wC/K2B+Sxv/AN9VW8UX4srua5UnOnaZc3jf3RwNuf8Avl/1pAeN2Wl32teIbvU9OV44raeXUy8IMcu+W4kEY3vJsK7FYtwoHJ2uTXs3g3VzqS3UTNoimJgVh0y8+0bQc5LkIoBJ9PevFPhhc3l2i2K2nnziG2mkitrdR9uhEAj/AHgdhFt3F1LsSSeiArmvb3XWotNsV0TTtLsjsPm21w5AiPZV8sY9cmhAdBVOdrp7+OD7JBJp7xt5sry/MG7KE2kMCM5JI+hq1FvMSGYKJNo3BTkA98H0rk7nwWZLma4TxN4nhkkdnxHfAqmTnCoVK4HQDFMBNeh0yw06K3ew1LS7eWV5muNJQp9nccb5PK9R6qy8fN0ri9cGrQahetdawNW0+70K4ksrmGRkDtARIC8aAxF/nA3jbkDpXczXsuleFI5TrqpPK6iC61yAR8k5CSKojwSARnAP16HkvE9tJeWmkW1x4bitrsXcv+pxNbkzQzAyxuMdWIJyA3OcHrSGel3F4i6PLeiPzYxAZgg/iG3OPxqTT7lb2wtrpFKrPEsoB7BgD/Wub+H1/Jqfh1Le6RQkVtbKoAIJR7aJuffLMPwq94Edz4S0yOXiS3jNq31iYx/+yUxG9WAi/bfG0spYGLTbQRquP+Wsxyx+oVE/76Nb9YXhUeYuq3h63OoTEZHaMiIfpH+tADfEEdkL+K/uLrbc6fZ3M0cOR91goaQjrxjGf9o1z/wssn07wtol1PrMDWU1hbQxWsUUcce/y0GWf7zyEgjqB2xxVvxJt/4rK9k4S30n7ODjphJZG/8AQk/Kql9aRan4P8PeHZxBNHetFbzCP+GOJN8n+63ybOOQW9aQGvp9pq1vHq2rNbW8mr3cgMNlJN5cUaISqAuqt8xUklsHqF6AVZ06/wDEC3BOt6ZpVnYojPJcQ6i0m3Az91ol465JIxWd4U8NWVlqlxenw/8AYJ4C0VrNLfNcs8ZzkgEny88cD1ryH402vxN1bVdQg8OTy2+kiK2NyhvFiiZudxhYhT5e5gG+bcSOmMCgZ7/dXM91pP2jQJLK4lkAaF5JCYXBPXcucjGelYD2GvQ3Ca0tvYyawENvNaW9wyQXMWQULMykhkO4g4PBI78c38JNM8XWi6lJ4pvvtl/DAlrC0tibZCRk5DK2JF5HzbA3JrudWttXu7yOCFtP/seWMx3SSCQTEEEHYynA4PcUCMPxGuqW3jrwrqPnQ/2SxktLmA43RSOh2srcFgWCgj2UjvVnQ7KG+sfFOi3W9rY308LDPOyZFkOP+/pqr4xuLKXwxaX1v5J+zgXFvJMD5o8plkIXIz0jO7PpWzpSiLxVrqAj96lvcYHurJn/AMhj8qANqGMRQxxhmYIoXLHJOPWn1h+FkMC6ra7ywhv5SoJztD4lx/5ErcpgZnie8On+HtRulJDxwOUx13Ywv64rO1mCPS/Dml6fAAsYubO1QegEqD+QNS+MgstjY2rH/j51C2TH94LIJCP++UNN8YsDHo8fIZ9RhcHsoTMjE+gCo1AHnviKeO/8T61bC605BeX6QFL2xW4UQ28MZkm3OdiCMyPywOSQO9aWtx6XrMNtbaUI4tL0yGR4520Lz7VECAkK74TPynBTrnH1y9FsLqXw9q2uX9tbRwamsk0Ut7ceTHbRyyed5hODjJdB2P7lcdqsfFJPFUfgbVdKsnfVbnUgkC3MipFDEjZ3+WkeZGAAH3yevU8goZqaHcSaZpVteJr3hWTw0ZF3vBphiOW4IJSUorEHBJXjuK1rnxd4Z0qG41FNesG06NFQ2dq0TZkLfeGPmZsFRjpgdK+U/hj/AMJv4b8cro0uq3ehaTc/6TdFImYTxwkIRCrKW3sQEAADZI9hXuvxm8F3niKz/tSP7Rd3dvP8trDF5Uy2gjcERjJLsGkBJGNwAGMgZAL9nejVb+5t4dWhvFnjANt4hgt0NxC8mNsbRbZFGeBvQ5OMZNXrW8SWbw2LicXv2LUptHknVw6zRSQM0bEjrkCIH/azXhP7P3hDUrD4s2mrW3hzWI9BCyQm51C1MXlyFSQQuenG3PIGeccCvXdQsL/wjqot3iju9Nv9Wtbzz4oREbTZKikusUYTDLjDMQeCDnGaAPSfBEjnwzawTEGWzL2bkHqYnMefxCg/jW1DLHNEksLrJE4DK6nIYHoQe9YnhoRxah4hto0ZNl95h3HqXijcke2Sf1o8DZj8N29q3DWcktoRnOBHIyD9FFMRvVkGCefxUJ5EYWtrabYyRw0kjfN+QjX/AL7rXooAwPEsrvqehWEUzxGa6M8hRiMxRKWIOOxbywfY1xfgWZNH8GJqtpps8us6zLNcpJOxYOrs0ocsCfLhUNnbwfQEsM6PxK1FrG18RXsTOJrHQ3SHbwRLOxVMHrkmNcVmfD63/wCEc0SPUvEM19c3SSNptiuJJHSNQF8tIQzjcWjbkDkKM4FIZo+D/B6zXlv4kv8AX7/Vbt3aZJJbNLfg5G3ayeYqDsoIGOec5Opr1pr9+JmaHwtcacrGSL7dFI+E9WPQHGeRXJahdTaPO93o9tdT6oimS4uNTnlkeCI4IaQBW2s5VkWGNMkHd8tR3GtNq2n6He2kktvDqyfaBDJrscJZ3b54xDKhEiqeNvTnoCaAO20sWlj4euoRpWntcNlJrPSlVY52Zcqql9ikspHJIHvWL4OgNjY6vaJ4c1I3EZMsUd6FRpgcjYJAxjyoYjcpGQRnnNeeT+J7i88VapJZl10TSrv+zI9MtoVjVIVYKJUKjccur4IwUcRYyCa9Vku28P3l5FdNr+o2d06PJdXBj8i1VyQdrgKwABGRzjA560AUfCbnUdS8XabJp97piTRQbbW7RQVBhMJKFWIZf3YGQSK3NKS51T4eWcdpcvb3k2nIscwJBSTyxg/99VXVW0/xtpQuUx9otLi0gdJGcFUaN0D7uS+0Oc89D61oeC4pY/CtjDcLLHIiMhDjDABiB9OMUCNxN2xd+N2OcdM0tVdLt5bTTbW3uJ2uZooljeZushAwWPuetWqYBWd4fuWvNNFw6bDJLKcewkYD9AK0ayPCTF9AtmKqpYyHCtkD5270AY3jw7PDfiJ1SMNJHFbuxJO5GIByPo7dKyPF0a6h8PNdnk0u3j8maVooWUTKzRuyZCFkCE4OSCPvE899bxrbMdK8UFYnOdPS4Vjnazx7zj6/Kv5iq8sZu/CuvhGUxC8eQZXG9PMEpGfQhiAfekMw72DXL7xOYm0vToFt0E5uGnnRogFDBWeJvmwSRtY8gcDGa5DxV4p1TxHdJqYtriz0WND9hL2gYTHbh7lizAL8rEIDuwrMSAx49evdct7DUm0XUYZEjnQJbzyPvE+4YK8/MSCSDgMAMEkZxXxneagNGv4dAksrKPUbS5/s+SOBHjNzsfa26RJFxHlAMkDOS2MgmgD0rUJtW1S5S4m1S5nvGdXA+1Jt3cAAxxPkdB0X8Ku/DfxR5N5f6L4qTTJdR0qVntnu5XtWSIuW2C4xlQGYDbJjOevYeJ6x4wvAZElu02SGa3kgjvZJo4f3mVaL944IXqrEHkkjJww7v4AafcSRXPiO8vWFpbq9hbN5r2yBcxmSRynIXBQb8EbiC4PWgD33x/D9qsP7ShksYr2+05bVbQoszP5syJuSQHkZlAJAIO6u28OMzy6wzHI+3uF+gVB/MGuS8YpHeeP/AAfaxtuEivMCHGNkckUuR6jMaj8RXW+EZDcaKt4V2/a5ZblRnPyO5Kf+O7aBCeGGhMeprB5vyahOH8zH3i2TjHbnitqsPww26517DblGosAf+2ceR+ea3KYGNoMv2nUdbnByguhAn0SNQf8Ax4tXI/E28mTwl42dXdUSKCzXDkYDhdx46cS8454rqvBREmgLOAR9ouLic56/NM5/kRXH/EGN7j4e+NTbKJZ/tisE6ZZDDhT/AN8ikBneBtLt7TRNU8QX95aafJNMVtr+9lMvkbP3ZOJQpyShI3HI3YGB163TrbV9StYrzSPG0N5bEn94LKGWN+xGUI6fWsawN/dwWrf2U0bWerSiVZIUuJvMkJdinzbI0G8jeWJ2jgAnFekoqoMIoUegGKEALnAycnuaxdZ8N2uq38V5NearBNGoQC1v5oEIBzyisFJ9yK26iWHbcyTeZId6quwn5VxnkD1OefoKYGde6lbtBFFFNDDeXnmRWsd4jL5jqDkbTgkcE+45rjxAbJbbTxpVxpskesW0vlxOZrZlckEwk42qdrZTA2k9MEE71lq7yQ30Om6vp2t6mk7tHbPIsDIgbDIdoY/LggMV5PX1rK03W7XRmmjih1CAz3LCbT7tsmzfyZZWZGJIZG8s4AJXOcY5FIYnwrSNIXEEhmh/s2wCybSu4CNlHB6cKK6HwigGnXIIB2392FOMYH2iSsL4T27RaVMzqQ6RWlscnP3LaNj/AOPO1bngkrJosk6fdnvLqUfQzyYP5UxG9WF4Hy/hTTpScmeMz9c/fYv/AOzVuMMqR6isLwEc+CtEHG5bSNGx2ZVAI/MGgDmfGErSeFvGsa4d7u7j0+Nc4yZI4IgPzc0t59tT4i6bFPrmjWltDFL5dmqp5xaQ7VABcMWIAbO0jII5zVTxLGZUSAvNEG8VRMxiXc/yxiUYBBzyoPQ10+r2sI8e+HrpgvmGC6jHyLknCEHOM9N3GccnikMji8P+ICyi58ZXzIDkiKytkZh6ElD+grqioK4YAj3qhqtjc3vki21S7sFQ5f7OkZMg44JdGx07Y60zW9Kk1SOFYtU1DT/LYktZuil+Ojblbj6YoERzWesvNqBj1e3jilUC1UWWWtzxkkl/n78YFc9eN4g0K/tZ9Q1u91K1dzvhs9EEgCjGdxQlh14PP0reudA+0aRb2LarqytCdwuo7nZM55+8wGD16YxwKrIkfht459Y8UztayHykTUngRS2MjDBFJPB7mgDImBvtJ8W3Nu889lc2b+WkksxcExHKiJwBH16AZz1rc0G2lkuodVEySW9zptvHwDuZlLtu+hD1kaNGt5pnirUWvfPjvJZ41ZVjCrHGGRcMqgtx3Yt04xUvhK9ma90u0ZtsL6FbziIfdVs4JH4ED8KANHQnYeJfEsTZx50Ei89jCo/9lNb9UrO4tZr/AFCOCPFxA6JO+zG4lAw574VhV2mBTvbKC7vLCWZ2ElpI08ShsAsUZMkd8Bz+OK4n4k3VzLczWNqSrGxFspydolu5lgQtj0HmGujOZPHqg4Ig0w49t8o/+N/pXN+Mw0MPjKUZE1vb2d/G+3OBEWYfk0TH8aANPwxqbah4VsVvre2iXcbdjbxmSEbZXiTy8g5IKIeRgA5qjqnh3TdOjhkvfDcGvXU0hWe9v5Y5PLjB4d5JenGPkQYzwMDmrmuX8NvYwNBqj22kpcyJM9tGWuZZd/ywRKq9Cd2SATge5Yb91cmfSreb9zaCZ4tyX6dFZhlCMjDnOByeSOD0oAxddgg066sBH4Tm1KztEU28ln5Ra2ZWBCqjspUcKcqTnABHArL8RfY/FItEv5b3w9fWhE0S3iwEZY4Xd8zDJ2tgBg2Ac8Vu+IvDz61pCRX0/mXcMjSI8JkhDKW+4VWQZyny5JxnnHavnr47eGrseFTqekeForObTnNveafFN9qVIpE3LcEJjDjBBJzwepHNID3Xw3a68xfUvEF1qpltQ3lWebeOOYbTyVjJ59Az4zzWXrE99Z6I2tXWoxWmoTaeAsczRNL/AK7eANvythW28Z69Sea8u/ZLfxNBBefbkZtMnRZWWVWMiqqkIRk9X3DGeqx56ba9V+Ictjq/h2OSOIG4W0muhHLaxyukarhssxyhVio+U7s9jg4BnR6EjjxT4mdkdUaW3CsRgNiFc49fSneFQVudfUn5RqTlfbMcZP6k1vJ90Z64rA8I4La5ICcvqc2cjHQKv/stMR0FYXhhxJd+IGUN/wAhFlOfaKIf0rdrC8JSGWDU2OM/2jcr09HK/wAhQBx3iG2XVPFY0+Yh4b/WbeOSN1yrQ2sH2ggjuDIVH410PgZbxtB0a4M0MdibaSWaMrlmld92cnoB831J9ueF8T3Op2Xj9l0jJv7a4urlUe3WXzIpLe3yUDSRjjbIPvfwnrXZfDTz5vBQyFls2MgtBKVZ3Qk5Mm35Rliw2jOFABJOTSA5TWtTkvLLxFdebBplopU3CGeNPtys2CPtB+7GY4x8w5G5sA7RVL4T38mqeFfD011q+l2cR1O7tktIkg8mdVnZlSLcu4gYCqEI4IPOK8K+MnxAvp7s6TdFlnsoUtWsZrSIQwgqjOqqdxVgygA8EAdcHFe6fs72EUXwt8G3N6l0JZbm6njWKOQpud3wXCfKq4HBbjpjnFAzyfQfGMei+J4RpEc0upySXVrNGJ9w3ecZA23/AHowcccyMK+mfCSJ4m8CaU+qtPO7RMrl3ZGcgNGd4BGSRnIPftkV8DeLGk0vxv4jtFZ0mj1C5jadZGRmXewIPqPbHOa/QTwC1kfBel3Gl/aDY3EP2qPz/vkSEyc/ixo6iOa0PV5r/wAM+Fr678h7q11NbKVonLYOHgOSQPm+YZHIz3NdzpOorqIuysTxm3uZLch8clT1HseteP8AhXUNMi0jTNJa0tLPxFLqFlczxQROpdfOR98jFQDJ87ErkkZr03wUo+x6lMDlZtTu2B9hKyf+y0DNqzuoLyIy2siyRh3jLL/eVirD8CCPwqesLwc2bC+Tj5NRu14/67uf61u0xBWL4VBis7y2Khfs97OgA7KXLr+jitqq9vaRwXF1NGW3XDh3BORkKF4HbhRQBV1G2kuLgxiMNBPbSwyN3UnG3v05btXHeGL4L4P1MvPHav8A2fBcC4uJFWJS1sq7snhQHjbOeODXa6rdzWYtXih82N7hIpcZyitwGH0Yrn2zXIaDdwaayWE9mAYNQm015nkCqsYDSwh/UFJOB0z9aQwe+fXrzS2e1d0nAMUKP5fnQjaWnkYDIiyflT+M4JH93558f/BDWNa+Jvii/uL+w0nT57iS9gkm3SM8ZG9nKoDtUHIy2MngZr6d0nRoLC7mt9P1BxNEYf3bjcY7YOzLGv8As/M6g+gA7VXtbW1ubRRqBeO61DVGZgyHMphkZkQ+ihIhjtj68iEfNTfs0alqEk0sfi+yku3YllmtJIyWKhyDzkHDDIxxn8K7b4ZeFb/wVov9mz65Zaikcn2i0e1mNusTTIDxKynDMoyuQUfLK3avW7TxHHbPby/ZIbaG9iS7kG47t0kyRbicdgwJqr4hS0tzbxWGnR2sjyTWry3J8pRED5kmAUdJEI3MFbAxuwQc07gZus3FzqGvRyRWypf2umJYxSs4Z1nvHUH7vy4RId5I45r0q2gjtbaK3gUJFEgRFHQKBgCuG8HK+paxHdNGYYEQ3yQABRGJB5duuB0IhjJx2MldN4suprXQrj7K7JdTlbaBl6h5GCKR9N2fwoA0bW1htEdLeNY1d2lbHdmOWJ9yTU1CjAAyTjuaKAMTwVIsvhbT2TpsKn6hiD+oNZ+q2MWq6f4u0VIW8y5iJO7oxkh2gj8U/MVd8J/uI9TsNu37JfShR/syHzV/STH4VIQ9v4vDM37m8swijtvicn8ysn/jtIDzv4GXkl1oup20TWMU6XcN66QjEaJIi7lG3bkjY4yw6jJz39erxLwBe/2V471zRHZ1jt5bqGNctOWXf5yLs7Da7YAHOepJruvD3ie+fUJ9N1W3N1cxSrH51lAEjRCoO6QNIzIeckEAj0NCA7Oq93HI4iaO5e3WOQO+1VO9QDlTkHA9xg8dakeZEt2myWjVS2UBYkD0A5P0Fcr4h1vwmb3TF1/UYbO5jC3lqt1M9r16E5Kg/wC63TuKYFbUbq5iuIdc0/XPD81pdMI7Rb+IRjB/gjnU55IJwVauU8e6jHp1/p2jXDzSXlxayyGCW5Moga4kjhyHIGVVWmxnnGcelWBd6FfXVr9r1fVit0Z5p4IdeMyWioC24+UxIU9Rzgd8cA5aeHJPFvxQmuLqC+s4I7QXBW6RSygx+TGDiZ+cGVuVU9TzzSA9N8FIX8NpdIoja/eS8UEfdWRi0fHshQY9q09C08aVo1lYB/M+zwrGXxjeQOW/E5NY3iS+STTtQ0fTi0dyq29vlflCCZ9g2kdwoJ9uK6emAVj+FrGbTdNktJ0CpHczmHDZzE0jMv04bH4VsVnadqD3Wp6rayIi/Y5URCDyytGrZP4lh+FAHDeLmaDxNBC7vEg1nTr5GDYysga3IHtuVQf9/wB6f4s1K8u77StU8OXi3Vkt6LNpCqiK1YkxtIrEAuW3hByVB5wSOL/xJzPD9ktbBJ9RW3/tC2k43SG2nhlMI4z82Bj6Voxx23iTwxe2di9uunXVohsTFEUEaPGCjemQ3IC9MDvSGPj8IWcnzatealq0m4Pm7uW2ZByMRptj/wDHau6Zql/eahLDPoV7ZWybgtzPLCQ5BwMKjs2D15ArK8G3k0lvJLqWtHVNQDJb3UNrGpgtZsZKLsBPBPJZj05x0rW1HxHpGm6nBp19fRQ3s4UxxMDlsnA7eopiG623iBbiL+w49KeDb+8F5JIjFs9ioIxiqdnd6xd3AsvEHhyAW0nBnt7tbmHpn5ldUYD6Kataz4n0rR7tba/luFmZN4WO0mlyPqikdulZ97cG+fT9WsdW1mzhkmSAWf2NVE5Ld0lj3rxnLAjAGaAOV1bVoPD3goQxyPpsckt5cCFNMlkR4WebEYKALGTuUgnp1xXVeHbH7P4hKnG600i0tSM9DukJ/wDQRWT4h8NW0Oj6daXFxqEk9zqcYOL2XY++YSOGRSqsuxW4K4HPHWrttqsem23ijX542kQ33kRopwWEeyEKM+sm/wDOkBsaCSdY8RHt9sQD/wAB4q26wvCLm4t9Su8YFxqE5U+qo3lA/iI81u0wMSFmPjS8Xedi6fAdnuZJef0qtrmlXF5NryhM299pQtVYNzvHmgjH0kHNTsTF45TP3bnTmx7mOQf/AB2maiTbeNdGnYt5VxbXFp148zKSL+O2OT8qAOW+HjTXHhKa6tLa2utXhRLm0WU7RvltYjnPVQWLg/Q1pfEHWYLHwxqhu55hLbvD+7tJP3kjnBCDbl0BIOT94DcRXGaJc3vhzXJtLttYsNPktftdt5N7F5iSRRubiFvlZWGIJjyCR8hB7Uz4jTT6r4N1/UPDfiFtUjntNt+umyQMsQ8sjbHtUy5Y4wCzcFhxnIQyx8NviIdQGs2NlDqur6jpzW4uEkKCOMO2xki27jlOp3sSdrZbgmut8eaRrRuIdQ8O38sU7MI5I5W3xpuGwMqmKQr1+YqVGOT3NeSfBrwHqnw/aGU2etXuqiHfexWAhWGBpACqMZZF8xgoGQvAyOc169faRFP4at7nxjBLrV3CCwVbI7lD4+VoY2YNjjOCelAEWpXA8L6TcLLrVpqGpXZUOupSrGu3bglIoUy3H8IGTxzxXNbo5PD2qI1q6fZNNSySBbI2K5nnO1UjySi/Kg55xyetbtjaaxdG1+16zpGim6AjRLLTfs95IijhB5zttwB02EgdMVWv7lHhW7Zg0N/qpvt4OQ1raIGDfQtCh/7aCgDrvCs8t3/a91I8jRSahKkIZsgJGFi+X0BaNj+Na9tbQ2qyLbxrGJJGlbHdmOSfxNY+hIui+CbQuuDbWQlkz3bZub9c1e8PJcR6DpyX0jy3Yt4/Odzks+0bifxzTEaFYfhMr5WqKhJ26jcZ+pbP9a3KwdGU2viXXbUhVSZor1AOp3Jsb9Ys/jQBympzNF8RLOWaZmSHWFhUM2QiTWDDaPT54wcerVq+HbWPw5Lq1hJO6hrv/RmWNpCqTsWQYGcBZDKNx64yTWP45AtNekmmIWH7dpF3uP8ACBcGJz7YymT/ALVanj/VdOsVnj1eymt4JIlVNT+0LEm4ElVJSRZiqnBO0dD9aQz5P/aS8NahN8WDPYW9xeDVVjjjmWFl864QCKQYIwDuTOBxggjjmvYr7SdQ8NaZptowcWOk2SWEd3bR/MrqgaXcfMBHzlvmG36969FtvDpvbX7FJqdpBrke1bhba5e6VIsHGY5y2SQVySAcYwelbHhzwhZ6Hp0tvEsV1NOBFcvNu2yx5OVKEkD5SRjoaAPkz4ufD7U7r4taNdW+nXLWviH7NPJIYCyJISFm3AE4GQXOWPDde9fYbaraWdvAsUsHlrZNchY9qoI1AwwGchfTAI96ydP8P6V4e0q5i1O7sotPaV3CBEtIERsfIQDhui5LE9Ow4rlNYnfVtX1S/g1xpNKulOlwCzjklYNIm390Aqo5HzOeZAAD0oAyvhRbWGp/2dq2qTKb6+db5GFxHcF5whkkBPlK8eAw+UsRjaAcivUfAkSw+D9JCqAJIFmOPV/nJ/Nq5nxGh0154Y5p7iTTNEeKGWZsu81w4RMkADJMeOAOtdnbGHSbfTNOAkYeWIUZVyFCJ1Y9hgfmaAKnhAf6BenC/NqN2fl7/v3H9K3KwPAaEeE9PkYkmdWucnv5jtJ/7NW/TEFV767isrcz3DbYVI3ueignGT7VYpHVXUq4DKRggjIIoAhvrdbuzmt2Z0EqFdyHBXPce4rhNZs7v+1Xklgnt11BoraSZU3iK7iO63uBt6o3CN0xhQcDNehUyRiuGyoQZLk+mO1AHD69LqKWthqqWNxFrVu0qFYFEu5AMurbmRWjJGQMg42kYORWe/jezEUdxfWOqxSx3plFveSRW8kP7vGPnZV2ZZgBuPr6V2uixrdaVJv1Qava3DM0c/yf6tv4cpgHHIz1rzfxH4Xj0p73WfDkF7YC6u2F3ax3Mts1zMzbQ7EyqhXpt24+936BDL+teK9LtdK0mXQZ9BIcNbPHdTrObZXwwyIixYblUEA45BzxSaJOPEtxqGm2lzqd6ZTGurX9zE8ESpjJgiRgOoyOFGFckkkjM2k+Go/JfEd3aeJxb+ZM0U0u4xtnbC1w5k25IySjbhjIx36uwntdJvLDQdOtEEhiM86wt8sC8/OxPLFn4GeT8x7GgRuoiJ9xVXoOBjpWTqFrNfeINNyv+hWQe4Zsj5piNiLjrwrOf++a2CQASTgCsTwliewn1LDA6jO9yC3Upwsf/jiofxpgbdFFFAGfb2Bg1u8vUKiO5iiVl5zvQsN3/fJUfhT9XlgtbM3tzG7paZm/d9RgEE4zzwTxTtWluoNNuJrCFZ7mNd6RMceZjkqPcjIHvil068t9U06C7tjvt503AMMHB6gjsR0IPQgigDy/4j+GW/t0avpkhjm1Hy/KlSIS7LpAdhGWUAuoUAhl+aNASQ2KxYtS07W7UvqSyTXls4iuPtVnbajHBIT/AAZYyFTzj5mA5XgjFeh6nYtY6ZcaVqVrLqHhuZfLR4FLTWi54BUclV42svzLgZHG6vGdb8F6jZ60YZtR+0XM7FrOa5CkX9sw3PuLNGFI43qGDZw49kB65oXiI2n9k6aiM1uzFHubmyfT4kXHyJGpXaT2C5H1q1rWr6vHcSollp0qW1vJLdW8s0hXbu+RgRAxY7VOVHc454NfLtj4q0/w7rUlyNL8KnUoDJFHIbyeaJFYMPlkjLBHIGOSSOuRmuivNUtNVi0yP+2tHklMTtd2UF3LfxxJg4VXllY7wByVQgds9aLgbOueIYdZiiuHv4G0eAn7bFZWLLbXMoXiGTDxtO4LAkfKmcDBJOPcPBejaf4Y8NtcJp8OlSXCi8vkQkhJNg3ZPPAAxjJxjv1rgvhz4Ds7rVrPWRDIPD1pFE2mW11AqvI4X/WHKK5Rf4N4DEncR0z6ff3jtrNrpa2omglikmupJAdiRjAA9CzMenore1AHOWcE9xqekeaGE1/dS6vcBhtZIkQJFGR6jdED7q1dzXO+F2GqXV7r3JiuSILPP/PuhOHH++xZvddldFTAK5+8lfTvGNnKxIs9SgNsxxws6EtHk/7SmQfVQK6Cq1/ZxX1uIph911kRu6OpBVh7ggUAZXi6CQWdvqdsjPc6ZMLkKoyzx4KyIPcoWwPUCua8MX1po73+kAXE9jERdWCW67lls7pwdwA5IjdnHHRcHvXZ6LqH9o2jPJF5FxFI0M8Jbd5bqeRnuCMEHuCK4XxZpd3oUtteaXshjsZJJ7K6dS0dvv8A9ZbTBfm8l+ocA7CBnhRkA2NcTVPC9n9o0MW76auFkhmRillEFwpjSMAlQfmbqSDx0rW8PXOo+YbfWLm3vJ5IxcRz2Vm8Vv5Z4C7y7hm79Rx2rntO8Q6ot5FaSWljYvO/zWF9f4u0ZmYs8Z/eLLGcMV+6MLjAxiqE2gjwPLDc6Ebz+zmBDKdUVEaVgRkxykRkkkNkMORjGKQHYX/iSC11I2CWGq3NyCozFZSeVg4581gI8AHn5v14pUs7u88Tm9u0EdjZIY7RNwJlkcDfKcdMD5AOvLnuK8xIfW9Sg0q+n1XVrx5FlFpqesWUULKnzHfDbbi68ZKspz7da7jxI6afplj4W0O3Z7y9QxQxpcSRi1hUfNMzqdwVcgAAgkkKCOwAut6hDNdz6nGWYaCZYhbujKZLt0QR4z1GJCoPffxUlxDaeHfBK218YLu6s7f7VslwxmnVg/mAHnJlIOexYVneG9ItBPa6TpbvLo+jS+bdXMkm9ry9HZmOSxQ/Mxz97aP4SK1taj/tTxHZaa0ULJHi8uJAPmEKkGNCf9qVc46YjNAGr4b00aRoGn6eMbreFUYj+JsfMfxOT+NaVFFMDB8RZttT0PUOdkVybeUjskqlRn/toI6k8XW8smkG5tYmlurGRLyFFPLlDkqPdl3L/wACq14hsDqei3lmpCySxny2P8LjlT+DAGl0PUU1XTIbpVMchyssR6xSKcOh9wQRQB5v8QSlvr2la7p7yGDUoU2XNtZ/aWWaEmaM4HIVozKrEc7RitmLxRZ6p4S065+1axo328F/tcVsJGgdWwY3JRlXOcDcoyKua/4WmPh++ttKaKR4pxfadbSIAkcgO5os/wBxyWGMcByOmMZFrHbzta6t4cmtPDekzWxnnnhgRC0iEoYp1ZNoClm6ENlTzgUgLereKv7LtYLGLXre21CFiss2vWUiCdeeVZPLT05GRiuc8TaxZeImsI7OPw54lv1h2s0NpPMdxPRdmQqdOXcDjrVzxf4r1GX+zjolzqfzx4nSyjjdWOOqusM43Z4IyMe9Z2ua1c2VxpsfibxFd21pEgdrCxjlMk3GQZLoGL5+uVCqB3B4oGVINGs/+Erj8ORajZ6Te7kN4mnWyWQKMu4wq2WkldhwfnCgEnBOAOq1uL+0NQuLGyjWK0YR6FaKi4G3Ie6ZfRVjQJx3UitOSeHRdLtbHw/HcjVtX+e2gurh7gwZA3SvuZsIgIJwcE4A5al8LWMQmfUohLcWWnwvZ2H8TzEHM03uzuuAe4XPRqALvjKa4mtTpSW7rFeyW9us4cYYO581QOvyxoxz/tD0NdNXOQTHV/FmVRlttJi+bd3uZVB2/VIzz/109q6OmIKxtQ22/iXS7gnHnxy2n1bAkX9I3/OtmsbxbbyzaLLNaqWu7NhdwAdWeP5tv/Ahlf8AgVAGR4/022u3sjfrmwu1k0q6I6qk+3Y2exEiIAe26say1fSrvQ7ez8dGzubu2eTTLhLqyMqtOgGZM4IUOhRucZDda7e5hsvEfh9o3LSWN/ACGU4O1hkMD2IyCD2Nch4osTot1bXt7f3S6bfRxWOp3Ucxt3SVTiG4LIRtBYlG7YZewpDK9jp/iDQLt7bT9Osb2XEcMOqS25BhUqCUb5t7xDAAbcWXgEEDdVuPw7a6jqlyviyx8MT6xNF5kcdsWSSUDjc+7kjgDODiqnh/W59Au5rDUNRsLtVlCzy3WvpI1ue4CtGrD6Enp171Bc+Lrm7vprvRfsGqJbyvbxXMWi3kpXn5lWWMMrDpkqcGgCmtvY22rR6fZ+GvC9rqcbhCyWlxemJjgg5WFQOuclwPeug8Y6wbK5h+xBJtWsIWE0v2KeVYFdQSyKMRgnH8bqAOM9aZouoamyX2ravqM2mWsUiPMlzZvbo4AwFQzSMFU9DhVJJ9a5nUmvvE9wl48sltPdXAg0+znikuE3beZVSQJGUQZYtsb2bkUAS+DoPt99DLKLp5NV1QXTvcyrK0kVrGP3hK5QAzFMKnyjjFeleI5r2HSdQaziErfZmWJUBZzKeF4/u8irljaCw0+3t0aSdreERLJK2XfAAyW9TjmuY8da7rPhmxW90vS4L+CQP532i+WHyZSAIxluNhb5TjuQemTQIXwZrxuda1Xw7BZk2ehpDbJfRyq6SMI13IQOVcHI288DPGRXYVieEdKOmaUvmvdPcz4lkN46yTISM+Wzj7wXkDJPHetumAUUUUAB6cUwt5cW6Q52jkgdfwp9FADEijRdsaBBu3EIMZP4Vz81t4siZ/s2qaNOhJ2rPYyIwGeMssuD/3yK2r+zivokjnMoVXWQGOVoyCpyOVIOPboe9YGq6nr0Pia106ytLM2dx84unjnk2KB8wbauxT6ZcZ9KANDSIdeDyNrN9p7qVwkdnauhU56lmds/kKuW9nZ2FxNJb26RzXku+V0QkyPjqx+gxzx2p3k3f9p+d9rX7F5W37N5Qzvz9/fn04xiq17psx0z7HpV49hl8tMF82RVJJbaXyAxzwSCB6UAZ+tSz6i40G2l3SyKPt9xGNoghPbqcO4yB6DLdhnoIY0hiSKJAkaKFVVGAAOABVbStNttLtBb2aFVzuZnYs8jHqzMeWY+pq5QAUUUUAFVLW1trO5m+zoY2unMzhQdpbgFvQE8fXr61booAK5fx5Y2ep2MdlrPho67pMmfNCBHeFuAGCEg9zyh3D0roohLFHIZ5BKdzMu1MELngYyckDjPeoxqFuNNW+nf7LbFBIzXI8rYD/AHg2Nv40AeN6n8Nvg9od9Haahp6200fz+U0twd4YYAzk5xnIAOc1teGLfwf4djdfBvhPU9QknHlPNHZP84ByA0s+0FQT6mut8UTKtpDqlv4kutPtWUIptoI7mOXPIIGxiT7g4rW0OJoLCJZb+6vpJR5olulVJCDg42hV2gemMjvQBBp9/eW+lfa/EiWtlK8oVYYWMgjDEKiFv4myeSABz7ZNLVo9R1i8XSADDYKu6/uVUp5qnpDHn1H3m7Dgcn5duzeS4WO5dZ7cMhBt5QuQc9TjPPHr3q1QA2KNIo0jiVURAFVVGAAOgAp1FFABRRRQBBO0VpDcXHlnhTI/lpuZsD0HJOBinWlxFd2sNzbOJIJkEiMP4lIyDUtVL5b4yWpsHt1QSjz1mUktHg52kHhunUEfzoAqTJcXeoX1rLZm3ia32wajGUckH7ylWBwQecEFSPypt5odreaTf6ff28N1aXIwYADGGUIqhSQePu9RgY7esOo3zXt7LpNtPe6ZfpiSC4a3DRTADJwTlWAzgrlW9Mda5LxDO1xcPBr1t4U1O9tQApXUzZzIDg4KkMVB6/ePakBPplnrmkaOIrey8N+EtPgj2vcFvOZVHQ7QERcerM30rb8EDTriK9u7A3d40rBJNVuRg3mB1Q8fu1yQNoC8nbnk1S8K+GdPni+2ah4e0iL5g9syXRvsjru3OoAPpjP1rpbjUEa9k0yzk26gIfNBeB2jQZwNxGBk84GQeKYGZcano2jaXeWFvaj7PZ7LYWkUOFlkkGVhQdGY5GR23ZPernhvTZrKCW5vyjaneESXBT7iYGFjT/ZUcD15PUmtGazt57m3uJoUea33eU7DJQsMEj0OOM/X1qegAooooAKybtbPQ/t+rFJwkoRrhYVLjjjzNg5zjGSOyj0rWooAy9efUI7SK70gefJA3mPbAgfaY8EFQx6NzkdASMHg5HPzaVdaZqyarolm9zYajIJL/TnKo8TuApuIt2NrY++uRu5I+bO7pJ4bm1mvr23kuLtmhHl2JdVTeufuEjgtkA5OOB05qlqk+ueZbS6PDaMPK3TWd5ujJPoJk3KrDpja2fWgDz3U/hnp8+sfajqt7Y23mti2NkJXdI/vDe+8kEAkHgkHiptFtNL0q4z4Q0W5Wa6ZYl1DWLdoIIixONiMqu7eyqAe7CtabXZZLa+jv/CUiI0ge6aDVLXZ5ikcs3mqRjaOoHTpWxpg8S6jqCXs8Ol6RZMULJE32q4nQZIVn+VFByem7qcGkBp6HoUWmtPcXE8l9qVyALi7mA3OB0VQOEQZOFHHJPJJJzdU1KLTdOtTYWl1DcRzNY2Gn4ES3L8qvyj/AJZgAtnjCgn0rp1ljeR0R1Z0IDqCMrkZGR2qu2nWzaomovHuu0iMKOxJ2KTk7R0BPGT1OB6UwIfD+mLpOmJblzLOzNLPMessrHLsfqTwOwwO1aNFFABRRRQBWt7draURwCGOxSMKkKR4Ktk55zjGMcYrD8UaZdu73lhbxahFLD9nvtMnICXUXP3SeA4y3XhgcEjgjoLtJZLWVLeUxTFSEcAHaex5BqI31vHeQWU9xCl9NGXSHd8zhcbioPJAzQByWj6NBZ+H57lLO41y2Ch7GxvrdBdQKODDvkxuwem85AGNxGDVnxRp+kTWcs13dyaX9lt0Pz3M0NvApY43LHIik5BHXPT2revYtNu9RtYbs2731uftEEZcCRe24DOcdvSqsE7yXGtqp1TMeAgkgUIDs/5YEj5+Rk5J59qQHMat4ntdY0f+zPCUF/qUwCAXCq8UMKqQdz3Ei+g6rufuB3rf8K+HTpm281C6e/1V4hCbh2ZhHHnIjTcS23PJLEsxGSeABUk1iOxtrSCa2udQ1+NB9mt5TGbl9wA3yFBtiXOQzcAYOM8A9JHdKslvb3UkSXssZfykbOcY3EZ5IBI59xQMklmWEgzMkcZIUMzYyxOAPxJA+prz3S5Br/j/AOyxXE+paPokbFp5fui8LSo6E4AfCNjGCBgYIIIOl8QPD2oa14M/sWK8mlnuryLzbvG14U84PvULjlMDH0Gc81ueE9Pk0vR1tZ4Y4pVlkLmN9wlJYnzPZn+8R/eJpiNmiiigAooooAKKKKACqtxb+beWkpXIhLHPmsuCVx90cN179Oo5q1SMWDKAuQTyc9KAFooooAQthgMHnv2FLRRQAUUUUAFFFFABTZY0ljKSoroeqsMg06igCve2v2mza3Saa2zjEkBCsuCDxkEdsdKWSztpbuG6kt4XuoVZY5mQF0DY3AHqAcDP0qYnBA5546UtABRRRQAUUUUAFFFFABRRRQAVj63oNrqkttK8dqJY5Vd3ktY5TIg6plgcA+o5GK2KKAKl3ptnd2Asp7dGtBtxEPlUbSCBgdsgcVboooAKKKKACiiigAooooAKKKKAOVvfBumXfixNVuLG1lTyjvR7S3ZWkzwxYx+Zu5PO7HHSuiurOC6EAmQnyZFlj2sVww6dDz16HirFFADUjRHdkRVZzliBgscY59eBTqKKACiiigAooooAKjmhjmA8xQWXO1v4lJBGQexwTyKkooA5XXPCv9qJpVvcfYL62tcLNLqFuZLlh/ejlRl2P74rDl1jWbPXLTRZJtGS7iwlvn7YQ2VwN3G1uPVzz6GvRqqyWpfUYLoSyDy43jMe9trbiDnbnaSMdSCeeCOcgxv2e5lsYY7i6Md0NjSS2yhQxBBIAbdhTyMcnB655q5RRQIKKKKACiiigAooooAKKKKACq93dx2rW4l3/vpBEpWNmwxzjOAcDjqcCrFc7r+m6Tqd5bS6oLfajrFbzNPyZd5zGqnjd8uMj5uuMYoA6KimRSK4YAjch2sNwJB9/wAMH8afQAUUUUAFFFFABRRRQAUUUUAYev6x/Z13aRiDU5FJ8yQ2ti86lORhiBxzg8c8dK3ByK5vVfDv9pahNN9pufmKFX+2zKIyCAyLHGygcA/NknJ7gYrX0dBFp0UInurjysxebcjEj7SRluBnp1xz15zmgC7RRRQAUUUUAFFFFAAfaiiigArF8Walb6Xpsc11c21vGZ413XCMynDZI+XkHAJB6DHNbVc7rOmnWtTESalqtrHbACWO2ma3RtwJDBwuWbgDAbAHXmgDfgmjuII5oHWSGRQ6OpyGUjIIPpT6zvD1vc2ukW8N7LNLcICGaaUSuOTgFwF3YGBnGfXmtGgAooooAKKKKACiiigAooooArXkyQNbl5dm+UIFyo3kg8c/nxzxVmvPviZb6vc3tq9piHTdOha+lleby1aRWGFz5b4IAJBwRycjvXfRMXiRiMFlBxnOPxoAfRRRQAUUUUAFFFFABRRRQAVSurgx6lZQiCRxLvzKMbUwOh5Bye2Aeh6VdrhPGmlzXuuC/tYYGl062WZJG0oXchYOSFR2dcEYztT5vU9BQB3dFMh3+UnmlTJtG4qCAT3wD0p9ABRRRQAUUUUAFFFFABRRRQAV4B8fpdctNa+H8Wk3kkAuNRT7KJApaO7Lj95KmD5ihHYYGMHJJOa9/qhcWsLTW3nWiSiKffAUX/VNtOXPp1YZHrQA+zhnhubgyLbeW4RvMjXa8j4wxcdOgXHt9BVyoraN44yJW3OSWJBOOT2yelS0AFFFFABRRRQAUUUUAFFFFAHj/wAZ38aRp4WfwFBbPKNXfz9iFd0hVwN6kY2Y37mJ67cV6rZLMksiyrIQyo5kaTIL4wygdgNoPpljTpN8MzOgLLJxg7jhug9gvHNPtYREjN5aJLId8uw5BfABP6CgCaiiigAooooAKKKKACiiigArxD47/EnUvBum+Hl0h/Pvbm8M7wSI8U0kaOSI9gH3CflJzk8YByce31zmr29shS11SWRLOW7ingneUu3nLIZdhyuEQbBjnoSOOMgFzQzFJLPdQwwRNeRw3Mu1yXMhTHzKRx8qoAe+DxxWvVWw/eCWdomieRyNroFbC8DOM5BwSPY9qtUAFFFFABRRRQAUUUUAFFFFAHlvj74iW3w/1TS1/sfU549X1No7t/KdvLAURqyYyDkhSqDkgNxmu98NzmewkDXP2kxXEsfmFtzcOcBuBhgMAjHGO9Y3iPSNLS9sLm80eW4S3vlvLV7be7LdNlS7oO3IO7kDknbjJ6PSoLi3063jvZY5rsIDNJGmxXf+IgdsnNAFuiiigAooooAKKKKACiiigBk7+XDI4KAqpOXOF6dz2FeU/Eb4k23gHXPCWk2tskzajcl7y2t42dvLfI3IQPmJkbdgcnB45r1hlDKVYAqRggjINcxqNnZ3Wp6LJq89rFdaTdCSHeB+9MkckSYJACsSScDPK4oA1tIuRLPqMCwzRi3uNu6Ry3mbkWTIzyB8+MdsVpVQ0Z7qW1kmvGJMsrvGhj2GOPPyqQec4GT9av0AFFFFABRRRQAUUUUAFFFFABRRXC658QI9K+KGieEjZ74r+LdLeb8CCRhKYoyMdX8mTv2oA7qiiigAooooAKKKKACiiigAooooAKK8v+I/xQm8H+NNM0RdPtLiK6ihld5rowufMuBDhBsKkjO47mUYB5r1CgAooooAKKKKACiiigAooooAKKK4rxl4o1my8S6d4f8AC2l2eoapcWs1/L9suWgjSCNkXAIVsszOAOw6nigDtaKKKACiiigAooooAKKKKACiiigAorzXx98R73wp4mubRNIgu9KsNOg1K/nNyUlSKSd4iY02EMV27iCwyMgc16VQAUUUUAFFFFABRRRQAUUUUAFNeNHK70Vtp3LkZwfUU6vMLz4mzxfFO58Ipa6ZGkE9tF5tzeMkswlRWPloEIJXceCR2554APT6KKKACiiigAooooAKKKKACiiigArhdY+F+g6t4ln8QXb3v9rvdW11FcrIoNuYNu1IxtxtO07gQSdzcjt3VFABRRRQAUUUUAFFFFABRRRQAUUUUAcV4x+HOmeK9dj1PUL7U4cW6Wk1tbyRrFcRLKJQr5Qt94D7rDpXa0UUAFFFFABRRRQAUUUUAFFFFABXK+MPBNn4m1Cwv31DVdLv7NJIUudNuBDI8T43xscHKkqD2IIyCK6qigAooooAKKKKACiiigAooooAKKKKAOK8VfDnS/E3iQavqN7qSq9rFZ3FlDKi29zFHK0qrINhcjcxzhhkAD1z2tFFABRRRQAUUUUAFFFFABRRRQAVxx8B26eNL3xLaa1rVpdX0kEl1bQSxiCYQqFVWBjLbcA5+b+I9K7GigAooooAKKKKACiiigD/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Normal; (B) Imperforate; (C) Microperforate; (D) Cribriform; (E) Septate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Reproduced with permission from: Laufer MR. Structural abnormalities of the female reproductive tract. In: Pediatric and adolescent gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"     </p>",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8514=[""].join("\n");
var outline_f8_20_8514=null;
var title_f8_20_8515="Patient information: Throat cancer (The Basics)";
var content_f8_20_8515=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"18\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83256\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/24/8580\">",
"         Throat",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?7/13/7378\">",
"         Patient information: Dysphagia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/27/17842\">",
"         Patient information: Hair loss from cancer treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/38/6755\">",
"         Patient information: Laryngeal cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/40/1667\">",
"         Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/36/579\">",
"         Patient information: Managing pain when you have cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/21/25939\">",
"         Patient information: Medical care during advanced illness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/53/6994\">",
"         Patient information: Mouth sores (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/57/19346\">",
"         Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/32/40450\">",
"         Patient information: Radiation therapy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/38/5731\">",
"         Patient information: Tongue cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/4/29762\">",
"         Patient information: When your cancer treatment makes you tired (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Throat cancer (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/throat-cancer-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H19882983\">",
"      <span class=\"h1\">",
"       What is throat cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Throat cancer happens when normal cells in the throat change into abnormal cells and grow out of control. The throat includes the area from the back of the nose and mouth to the windpipe and esophagus (the tube that carries food from the mouth to the stomach) (",
"      <a class=\"graphic graphic_figure graphicRef83210 \" href=\"UTD.htm?8/24/8580\">",
"       figure 1",
"      </a>",
"      ). The medical term for the throat is the &ldquo;pharynx.&rdquo; Throat cancer is different than cancer of the tongue or voice box (vocal cords).",
"     </p>",
"     <p>",
"      There are different types of throat cancer, depending on the part of the throat and cells involved.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19882998\">",
"      <span class=\"h1\">",
"       What are the symptoms of throat cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms depend a lot on where in the throat the cancer is. They can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Mouth sores or bleeding in the mouth",
"       </li>",
"       <li>",
"        A sore throat",
"       </li>",
"       <li>",
"        Trouble swallowing",
"       </li>",
"       <li>",
"        A hoarse voice",
"       </li>",
"       <li>",
"        A long-lasting cough or coughing up blood",
"       </li>",
"       <li>",
"        A lump in the neck",
"       </li>",
"       <li>",
"        Ear pain, hearing loss, or ringing in the ears",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      All of these symptoms can also be caused by conditions that are not throat cancer. But if you have these symptoms, tell your doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883013\">",
"      <span class=\"h1\">",
"       Is there a test for throat cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will ask about your symptoms and do an exam. During the exam, he or she might use a special mirror to look in your throat.",
"     </p>",
"     <p>",
"      Your doctor will also probably look down your throat using a &ldquo;scope,&rdquo; which is a thin tube with a camera and light on the end. During this procedure, he or she might do a test called a biopsy. For a biopsy, the doctor takes a small sample of tissue from the area that looks like cancer. Then another doctor looks at the sample under a microscope.",
"     </p>",
"     <p>",
"      Other tests for throat cancer can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An imaging test, such as an MRI, CT, or PET scan &ndash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"       <li>",
"        Fine needle aspiration &ndash; This test is usually done if people have a lump in their neck. The doctor puts a thin needle in the lump and removes a small sample of tissue. Then another doctor looks at the tissue under a microscope.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883028\">",
"      <span class=\"h1\">",
"       What is cancer staging?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cancer staging is a way in which doctors find out if a cancer has spread past the layer of tissue where it began, and, if so, how far.",
"     </p>",
"     <p>",
"      The right treatment for you will depend a lot on the type and stage of your throat cancer and your other medical problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883043\">",
"      <span class=\"h1\">",
"       How is throat cancer treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment for throat cancer involves 1 or more of the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Surgery to remove the cancer &ndash; Sometimes, the surgeon needs to remove part of your throat in order to remove the cancer. If this happens, he or she will &ldquo;rebuild&rdquo; your throat during surgery.",
"       </li>",
"       <li>",
"        Chemotherapy &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"       <li>",
"        Radiation therapy &ndash; Radiation kills cancer cells.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      After treatment with surgery or radiation, people can have problems chewing, eating, or talking. If this happens, you will have treatment called rehabilitation, or &ldquo;rehab&rdquo; for short. During rehab, doctors, nurses, and other health professionals will work with you on chewing, eating, and talking.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883058\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor will check you every so often to see if the cancer comes back. Follow-up tests can include exams, blood tests, and imaging tests. People who are treated for throat cancer also need to take care of their teeth and see their dentist for regular follow-ups.",
"     </p>",
"     <p>",
"      You should also watch for the symptoms listed above. Having those symptoms could mean your throat cancer has come back. Tell your doctor or nurse if you have any symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883073\">",
"      <span class=\"h1\">",
"       What happens if my throat cancer comes back or spreads?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your throat cancer comes back or spreads, you might have more surgery, radiation, or chemotherapy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883088\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It&rsquo;s important to follow all of your doctor&rsquo;s instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for throat cancer involves making many choices, such as what treatment to have. Always let your doctors and nurses know how you feel about a treatment. Any time you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H19883103\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/38/5731?source=see_link\">",
"       Patient information: Tongue cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/38/6755?source=see_link\">",
"       Patient information: Laryngeal cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7378?source=see_link\">",
"       Patient information: Dysphagia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/53/6994?source=see_link\">",
"       Patient information: Mouth sores (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=see_link\">",
"       Patient information: Radiation therapy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/36/579?source=see_link\">",
"       Patient information: Managing pain when you have cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/4/29762?source=see_link\">",
"       Patient information: When your cancer treatment makes you tired (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/40/1667?source=see_link\">",
"       Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/57/19346?source=see_link\">",
"       Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/27/17842?source=see_link\">",
"       Patient information: Hair loss from cancer treatment (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=see_link\">",
"       Patient information: Medical care during advanced illness (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?8/20/8515?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83256 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.243-7F1A92C927-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8515=[""].join("\n");
var outline_f8_20_8515=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19882983\">",
"      What is throat cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19882998\">",
"      What are the symptoms of throat cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883013\">",
"      Is there a test for throat cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883028\">",
"      What is cancer staging?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883043\">",
"      How is throat cancer treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883058\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883073\">",
"      What happens if my throat cancer comes back or spreads?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883088\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19883103\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83256\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/24/8580\">",
"      Throat",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/13/7378?source=related_link\">",
"      Patient information: Dysphagia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/27/17842?source=related_link\">",
"      Patient information: Hair loss from cancer treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/38/6755?source=related_link\">",
"      Patient information: Laryngeal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/40/1667?source=related_link\">",
"      Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/36/579?source=related_link\">",
"      Patient information: Managing pain when you have cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=related_link\">",
"      Patient information: Medical care during advanced illness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/53/6994?source=related_link\">",
"      Patient information: Mouth sores (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/57/19346?source=related_link\">",
"      Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=related_link\">",
"      Patient information: Radiation therapy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/38/5731?source=related_link\">",
"      Patient information: Tongue cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/4/29762?source=related_link\">",
"      Patient information: When your cancer treatment makes you tired (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_20_8516="Dihydrocodeine, chlorpheniramine, and phenylephrine: Drug information";
var content_f8_20_8516=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dihydrocodeine, chlorpheniramine, and phenylephrine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?15/8/15493?source=see_link\">",
"    see \"Dihydrocodeine, chlorpheniramine, and phenylephrine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F160362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Coldcough PD;",
"     </li>",
"     <li>",
"      Novahistine DH;",
"     </li>",
"     <li>",
"      Tusscough DHC&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F160372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alkylamine Derivative;",
"     </li>",
"     <li>",
"      Alpha-Adrenergic Agonist;",
"     </li>",
"     <li>",
"      Analgesic, Opioid;",
"     </li>",
"     <li>",
"      Antitussive;",
"     </li>",
"     <li>",
"      Decongestant;",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, First Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F160364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Cough and congestion:",
"     </b>",
"     (Novahistine DH): Oral: 5-10 mL every 4-6 hours as needed (maximum: 40 mL/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F160369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Cough and congestion:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children 2-6 years (Novahistine DH): 1.25-2.5 mL every 4-6 hours as needed (maximum: 10 mL/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children 6-12 years (Novahistine DH): 2.5-5 mL every 4-6 hours as needed (maximum: 20 mL/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F160354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Novahistine DH: Dihydrocodeine bitartrate 7.5 mg, chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg per 5 mL (480 mL) [ethanol free, sugar free; contains propylene glycol; strawberry flavor; C-III]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Coldcough PD: Dihydrocodeine bitartrate 3 mg, chlorpheniramine maleate 2 mg, and phenylephrine hydrochloride 7.5 mg per 5 mL (120 mL) [ethanol free, sugar free; grape flavor; C-V]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tusscough DHC&trade;: Dihydrocodeine bitartrate 3 mg, chlorpheniramine maleate 5 mg, and phenylephrine hydrochloride 20 mg per 5 mL (473 mL) [ethanol free, sugar free, dye free; contains benzoic acid, propylene glycol; grape flavor; C-III]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F160343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F160374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III; C-V",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F160356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic relief of cough and congestion associated with the upper respiratory tract",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F14199153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F160370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F160358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dihydrocodeine, chlorpheniramine, phenylephrine, codeine, sympathomimetic amines, antihistamines, or any component of the formulation; significant respiratory depression (in unmonitored settings), acute asthma, severe bronchial asthma, hypercapnia; paralytic ileus, peptic ulcer; use with or within 14 days of MAO inhibitors; severe hypertension, severe coronary artery disease; narrow angle glaucoma; urinary retention; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F160345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension; use with caution in patients not able to maintain blood pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenanthrene hypersensitivity: Use with caution in patients with hypersensitivity reactions to other phenanthrene-derivative opioid agonists (eg, hydrocodone, hydromorphone, levorphanol, oxycodone, oxymorphone).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (including hypertension and ischemic heart disease). Use is contraindicated with severe disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression/coma: Use with caution in patients with CNS depression or coma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Delirium tremens: Use caution in patients with delirium tremens.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intraocular pressure: Use with caution in patients with increased intraocular pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pulmonary disease or decreased ventilatory function; dose-related respiratory depression occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use caution in patients with a history of seizure disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Antihistamines may cause excitation in young children. Safety and efficacy have not been established in children &lt;2 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cough: Appropriate use: Underlying cause of cough should be determined prior to prescribing.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F160349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Alpha1-Agonists may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha1-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha1-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Alpha1-Agonists may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: May enhance the vasoconstricting effect of Phenylephrine (Systemic). Management: Avoid the use of hyaluronidase to enhance dispersion or absorption of phenylephrine.  Use of hyaluronidase for other purposes in patients receiving phenylephrine may be considered as clinically indicated.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Alpha1-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the vasopressor effect of Alpha1-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F160361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual monographs for Codeine, Chlorpheniramine, and Phenylephrine.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F160344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dihydrocodeine: Binds to opiate receptors in the CNS; suppresses cough in medullary center; produces generalized CNS depression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Chlorpheniramine: Competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Phenylephrine: Potent, direct-acting alpha-adrenergic stimulator with weak beta-adrenergic activity; causes vasoconstriction of the arterioles of the nasal mucosa and conjunctiva",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8799 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8516=[""].join("\n");
var outline_f8_20_8516=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160362\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160372\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160364\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160369\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062957\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160354\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160343\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160374\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160356\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14199153\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160370\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160358\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160345\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299200\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160349\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160361\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160344\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8799\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8799|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?15/8/15493?source=related_link\">",
"      Dihydrocodeine, chlorpheniramine, and phenylephrine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_20_8517="Lichenification";
var content_f8_20_8517=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichenification",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Thickened skin with accentuated skin lines are present in this patient who chronically rubbed and scratched this area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8517=[""].join("\n");
var outline_f8_20_8517=null;
var title_f8_20_8518="Acne excoriee";
var content_f8_20_8518=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Acne excori&eacute;e",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 531px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple small excoriated lesions on the face of a thirty-year-old woman who cleared completely after treatment with fluoxetine, a selective serotonin reuptake inhibitor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8518=[""].join("\n");
var outline_f8_20_8518=null;
var title_f8_20_8519="Treatment of streptococcal toxic shock syndrome";
var content_f8_20_8519=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of streptococcal toxic shock syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8519/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8519/contributors\">",
"     Dennis L Stevens, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8519/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8519/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8519/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8519/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/20/8519/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group A streptococcus (GAS, eg, Streptococcus pyogenes) is an aerobic gram-positive coccus that causes pharyngitis and a spectrum of skin and soft tissue infections such as impetigo, erysipelas, and localized cellulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/1\">",
"     1",
"    </a>",
"    ]. Less commonly, GAS causes invasive disease such as bacteremia, necrotizing fasciitis, pneumonia and puerperal sepsis, and the infection may be complicated by toxic shock syndrome in approximately one-third of these patients. The treatment of GAS toxic shock syndrome (TSS) will be reviewed here. The epidemiology, clinical features, and diagnosis of GAS TSS and a discussion of GAS invasive disease including necrotizing infections of the skin and fascia, gangrenous myositis, and GAS bacteremia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6616?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"     \"Necrotizing soft tissue infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42551?source=see_link\">",
"     \"Group A streptococcal (Streptococcus pyogenes) bacteremia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal management of a patient with GAS TSS requires a team of clinicians including surgeons and infectious disease and critical care specialists. Treatment includes management of the complications of sepsis, aggressive surgical debridement if a site of infection is identified, and antibiotics for the underlying infection (",
"    <a class=\"graphic graphic_table graphicRef57969 \" href=\"UTD.htm?38/7/39036\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hemodynamic support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Massive amounts of intravenous fluids (10 to 20",
"    <span class=\"nowrap\">",
"     L/day)",
"    </span>",
"    are often necessary to maintain perfusion because of intractable hypotension and diffuse capillary leak, even though anasarca is a predictable complication. Although the blood pressure may improve with fluids alone, vasopressors (eg, dopamine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    norepinephrine) may also be required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/35/40505?source=see_link\">",
"     \"Use of vasopressors and inotropes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Surgical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt and aggressive exploration and debridement of suspected deep-seated S. pyogenes infection is mandatory [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/2\">",
"     2",
"    </a>",
"    ]. Surgical intervention should be considered in patients who initially have fever and excruciating pain followed by progression to soft tissue swelling and the formation of violaceous or bluish vesicles and bullae.",
"   </p>",
"   <p>",
"    The frequent need for surgery is illustrated in a retrospective series in which, 13 of 20 patients underwent major surgical procedures that included fasciotomy, surgical debridement, exploratory laparotomy, intraocular aspiration, amputation, or hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is critically important that surgeons be involved early in such cases, since surgical intervention may be impossible later in the course due to toxicity or because infection has extended to vital areas that are difficult to debride (eg, head and neck, thorax, or abdomen). Surgical debridement may be too late by the time the patient develops systemic toxicity and definite evidence of necrotizing fasciitis or myositis. Surgical exploration through a small incision with visualization of muscle and fascia and Gram's stain of involved tissue may provide an early and definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"     \"Necrotizing soft tissue infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Presumptive therapy should be initiated pending culture results because of the severity of the illness. S. pyogenes remains exquisitely susceptible to beta-lactam antibiotics. Numerous studies have demonstrated the efficacy of penicillin preparations in treating erysipelas, impetigo, and cellulitis.",
"   </p>",
"   <p>",
"    However, aggressive GAS infections such as necrotizing fasciitis, empyema, burn wound sepsis, subcutaneous gangrene, and myositis are associated with a high mortality and extensive morbidity when penicillin is used alone [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/2-8\">",
"     2-8",
"    </a>",
"    ]. As an example, a report of 25 cases of streptococcal myositis treated with penicillin, described an overall mortality of 85 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"     \"Necrotizing soft tissue infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Mechanisms of penicillin failure when used alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies in experimental infection suggest that penicillin fails when large numbers of organisms are present [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In a mouse model of myositis due to S. pyogenes, penicillin was ineffective when treatment was delayed for two hours after initiation of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/10\">",
"     10",
"    </a>",
"    ]. Survival of erythromycin-treated mice was greater than that of both penicillin-treated mice and untreated controls if treatment was initiated within two hours. Mice receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , however, had survival rates of 100 percent, 100 percent, 80 percent, and 70 percent when treatment was delayed 0, 2, 6, and 16.5 hours, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Eagle suggested that penicillin failed in this type of infection because of the \"physiologic state of the organism\" [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/9\">",
"     9",
"    </a>",
"    ]. This phenomenon has been attributed to the inoculum effect in vitro and in vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Penicillin and other beta-lactam antibiotics are most effective against rapidly growing bacteria. As a result, they would be expected to have the greatest efficacy when organisms are growing rapidly in the early stages of infection. On the other hand, the efficacy of beta lactams may decrease when bacterial growth slows as higher concentrations of GAS accumulate. S. pyogenes achieves concentrations in deep-seated infection that are sufficiently high to reduce the effectiveness of beta-lactam antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is now a better understanding of the mechanism by which penicillin becomes less effective when high concentrations of GAS are present or when they are making the transition from the logarithmic to the stationary phase of growth. Since penicillin mediates its antibacterial action against GAS by intimately interacting with penicillin-binding proteins (PBP), investigators compared the PBP patterns of Group A streptococci at different stages of growth. Binding of radiolabeled penicillin by all PBPs was decreased in stationary cells relative to cells in the logarithmic phase of growth; furthermore, PBPs 1 and 4 were undetectable at 36 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/12\">",
"     12",
"    </a>",
"    ]. Thus, the loss of certain PBPs during stationary-phase growth in vitro may be responsible for the inoculum effect observed in vivo and may account for the failure of penicillin monotherapy in both experimental and human cases of severe streptococcal infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Clindamycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The shortcomings of penicillin in treating GAS infections have prompted alternative antibiotic approaches. A retrospective review of 56 children with invasive GAS infections noted that a favorable outcome was more likely in patients who received a protein synthesis-inhibiting antibiotic (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ) compared to those who received only a cell wall-inhibiting antibiotic (eg, beta-lactams) (83 versus 14 percent with beta-lactams had a favorable outcome) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     Clindamycin",
"    </a>",
"    has several potential advantages in treating GAS infections:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The efficacy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      is not affected by inoculum size or stage of growth [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/12,15\">",
"       12,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      suppresses the synthesis of bacterial toxins [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/16-18\">",
"       16-18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      facilitates phagocytosis of S. pyogenes by inhibiting synthesis of the antiphagocytic M-protein [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      suppresses synthesis of penicillin-binding proteins, which, in addition to being targets for penicillin, are involved in cell wall synthesis and degradation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/15\">",
"       15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      has a longer postantibiotic effect than beta-lactams such as penicillin",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      causes suppression of tumor necrosis factor [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A retrospective analysis demonstrated that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      use was associated with better outcomes than beta-lactam antibiotics alone in patients with GAS TSS [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Empiric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For individuals presenting with the clinical manifestations of GAS TSS prior to microbiologic identification of GAS, we recommend empiric therapy with broad-spectrum antibiotics as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      (900 mg IV every eight hours)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    plus one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A carbapenem (eg, imipenem 500 mg every six hours OR",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/38/32359?source=see_link\">",
"       meropenem",
"      </a>",
"      1 g every eight hours)",
"     </li>",
"     <li>",
"      A combination drug containing a penicillin plus beta-lactamase inhibitor (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/45/42710?source=see_link\">",
"       ticarcillin-clavulanate",
"      </a>",
"      3.1 g every four hours OR",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"       piperacillin-tazobactam",
"      </a>",
"      4.5 g every six hours)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Tailored therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of GAS TSS is established, we recommend therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (900 mg IV every eight hours) in addition to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     penicillin G",
"    </a>",
"    (4 million units IV every four hours in patients with normal renal function). In vitro, there are no additive, synergistic or antagonistic effects of penicillin when added to clindamycin. Penicillin is added to clindamycin primarily to cover the patient in the rare event that the organism is resistant to clindamycin; this occurs in less than one percent of isolates in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, it is important to note that an increasing number of GAS isolates with constitutive or inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , have been identified in Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no clinical studies addressing the optimal duration of antibiotic therapy in GAS TSS. We recommend that the duration of antibiotic therapy be individualized. Patients who are bacteremic should treated for a minimum of 14 days. In patients with complicating deep-seated infections such as necrotizing fasciitis, length of therapy depends on the clinical course and the adequacy of surgical debridement; therapy is usually continued for 14 days from the last positive culture obtained during surgical debridement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Adjunctive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other modalities have been used in patients with GAS TSS: intravenous immune globulin (IVIG), hyperbaric oxygen, and anti-TNF antibody.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Intravenous immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;IVIG may have a variety of mechanisms for treatment of GAS TSS, including neutralization of streptococcal toxins, inhibition of T-cell proliferation, and inhibition of other putative virulence factors such as TNF-alpha and IL-6 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/22-27\">",
"     22-27",
"    </a>",
"    ]. Some IVIG preparations contain neutralizing antibodies against several streptococcal toxins such as the pyrogenic exotoxins (SPEA, SPEB, SPEC, and MF), streptolysin O, and DNase B; specific antibody preparations are not commercially available [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Differences between neutralizing activities have been observed in different batches of IVIG from different manufacturers.",
"   </p>",
"   <p>",
"    In one study, Vigam-S (obtained from plasma collected from donors in the United States) had consistently high inhibition against all superantigens, while European IVIG preparations had the lowest activity; an Australian preparation had intermediate activity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on these data, gamma globulin preparations have been used to treat patients with GAS TSS [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/25,30-34\">",
"     25,30-34",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial case reports described two patients who improved dramatically following IVIG administration [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/31,32\">",
"       31,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two retrospective series described 27 patients with GAS TSS who were treated with IVIG (median dose 2",
"      <span class=\"nowrap\">",
"       g/kg)",
"      </span>",
"      and compared with historical controls [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/25,33\">",
"       25,33",
"      </a>",
"      ]. Mortality was significantly lower in the patients treated with IVIG, but the use of historical controls in these studies posed potential difficulties in interpreting the results since significantly fewer controls than case patients received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      therapy or surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=see_link\">",
"       \"General principles in the use of immune globulin\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A randomized trial including 21 patients compared IVIG to placebo in adults with GAS TSS (IVIG dosing was 1",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      day 1; and 0.5",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      days 2 and 3; all patients also received intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      and penicillin for at least 14 days) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/34\">",
"       34",
"      </a>",
"      ]. The mortality rate was 4 of 11 (36 percent) in the placebo group compared to 1 in 10 (10 percent) in the IVIG group, but statistical significance was not reached. In the 13 patients with necrotizing fasciitis, there was no reduction in the \"time to no further progression of necrotizing fasciitis\" (69 hr for the IVIG group compared to 36 hr for the placebo group).",
"     </li>",
"     <li>",
"      A retrospective study including 192 children with GAS TSS did not demonstrate improved outcomes with IVIG, although the overall mortality due to this disease is lower among children than adults [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional studies are needed before a strong recommendation can be made regarding use of IVIG in GAS TSS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Hyperbaric oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of hyperbaric oxygen has been reported in a handful of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/1\">",
"     1",
"    </a>",
"    ]. No controlled studies are underway and it is not clear if this treatment is useful. We do not recommend the use of hyperbaric oxygen therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=see_link\">",
"     \"Hyperbaric oxygen therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Anti-TNF antibody",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proposed role for TNF in shock and organ failure provided the rationale for the evaluation of anti-TNF antibodies in severe streptococcal infections in a baboon model of GAS TSS with promising results [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/36\">",
"     36",
"    </a>",
"    ]. This treatment has not been studied in human clinical trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall mortality rate in GAS TSS varies in different series from 30 to 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/2,30,37-40\">",
"     2,30,37-40",
"    </a>",
"    ]. Mortality rates are lower in children than adults, with a mortality rate of 18 percent reported in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective study of 66 patients with GAS TSS (30 who died and 36 who survived) in Japan, compared physical and laboratory findings on admission that differentiated survivors from those who died [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8519/abstract/39\">",
"     39",
"    </a>",
"    ]. The following statistically significant findings were noted in patients who died:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lower white blood cell (WBC) count (mean WBC count, 1000 cells per microL in those who died versus 16,000 cells per microL in survivors)",
"     </li>",
"     <li>",
"      Lower platelet counts (mean platelet counts, 120,000 per microL in those who died versus 170,000 per microL in survivors)",
"     </li>",
"     <li>",
"      Higher serum creatinine (mean 3.0 versus 2.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      in survivors)",
"     </li>",
"     <li>",
"      Lower body temperature (mean 37.0 versus 38.3 &ordm;C)",
"     </li>",
"     <li>",
"      Lower systolic blood pressure (mean 99 versus 120 mmHg)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Optimal management of a patient with GAS TSS includes management of the complications of sepsis, aggressive surgical debridement if a site of infection is identified, and antibiotics for the underlying infection. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend prompt and aggressive exploration and debridement of suspected deep-seated group A streptococcal infections (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who present with the clinical manifestations of GAS TSS prior to the identification of GAS by culture, we recommend empiric therapy with broad-spectrum antibiotics which should include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Antibiotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the diagnosis of GAS TSS is established, we recommend therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (900 mg IV every eight hours) in addition to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      (4 million units IV every four hours) once the diagnosis of GAS TSS is established (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Antibiotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration of antibiotic therapy for GAS TSS should be individualized. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest therapy with intravenous immune globulin (1",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      day one, followed by 0.5",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      on days two and three) in patients with GAS TSS (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Intravenous immune globulin'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/1\">",
"      Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/2\">",
"      Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/3\">",
"      Gaworzewska, ET, Coleman, G. Correspondence: Group A streptococcal infections and a toxic shock-like syndrome. N Engl J Med 1989; 321:1546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/4\">",
"      Martin PR, H&oslash;iby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990; 22:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/5\">",
"      Hr&iacute;balov&aacute; V. Streptococcus pyogenes and the toxic shock syndrome. Ann Intern Med 1988; 108:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/6\">",
"      Adams EM, Gudmundsson S, Yocum DE, et al. Streptococcal myositis. Arch Intern Med 1985; 145:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/7\">",
"      Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/8\">",
"      K&ouml;hler W. Streptococcal toxic shock syndrome. Zentralbl Bakteriol 1990; 272:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/9\">",
"      EAGLE H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952; 13:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/10\">",
"      Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/11\">",
"      Stevens DL, Bryant AE, Yan S. Invasive group A streptococcal infection: New concepts in antibiotic treatment. Int J Antimicrob Agents 1994; 4:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/12\">",
"      Stevens DL, Yan S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 1993; 167:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/13\">",
"      Yan S, Mendelman PM, Stevens DL. The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4. FEMS Microbiol Lett 1993; 110:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/14\">",
"      Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999; 18:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/15\">",
"      Yan S, Bohach GA, Stevens DL. Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes. J Infect Dis 1994; 170:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/16\">",
"      Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother 1987; 31:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/17\">",
"      Gemmell CG, Peterson PK, Schmeling D, et al. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 1981; 67:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/18\">",
"      Mascini EM, Jansze M, Schouls LM, et al. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents 2001; 18:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/19\">",
"      Stevens DL, Bryant AE, Hackett SP. Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis 1995; 20 Suppl 2:S154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/20\">",
"      Richter SS, Heilmann KP, Beekmann SE, et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis 2005; 41:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/21\">",
"      Gooskens J, Neeling AJ, Willems RJ, et al. Streptococcal toxic shock syndrome by an iMLS resistant M type 77 Streptococcus pyogenes in the Netherlands. Scand J Infect Dis 2005; 37:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/22\">",
"      Norrby-Teglund A, Kaul R, Low DE, et al. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 1996; 156:3057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/23\">",
"      Norrby-Teglund A, Kaul R, Low DE, et al. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect Immun 1996; 64:5395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/24\">",
"      Darenberg J, S&ouml;derquist B, Normark BH, Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 2004; 38:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/25\">",
"      Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999; 28:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/26\">",
"      Shimozato T, Iwata M, Tamura N. Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infect Immun 1990; 58:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/27\">",
"      Achiron A, Margalit R, Hershkoviz R, et al. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest 1994; 93:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/28\">",
"      Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/29\">",
"      Schrage B, Duan G, Yang LP, et al. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome. Clin Infect Dis 2006; 43:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/30\">",
"      Stegmayr B, Bj&ouml;rck S, Holm S, et al. Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scand J Infect Dis 1992; 24:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/31\">",
"      Barry W, Hudgins L, Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992; 267:3315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/32\">",
"      Yong JM. Necrotising fasciitis. Lancet 1994; 343:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/33\">",
"      Norrby-Teglund A, Muller MP, Mcgeer A, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 2005; 37:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/34\">",
"      Darenberg J, Ihendyane N, Sj&ouml;lin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/35\">",
"      Shah SS, Hall M, Srivastava R, et al. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 2009; 49:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/36\">",
"      Stevens DL, Bryant AE, Hackett SP, et al. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis 1996; 173:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/37\">",
"      Ekelund K, Skinh&oslash;j P, Madsen J, Konradsen HB. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol 2005; 43:1789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/38\">",
"      Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993; 16:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/39\">",
"      Hasegawa T, Hashikawa SN, Nakamura T, et al. Factors determining prognosis in streptococcal toxic shock-like syndrome: results of a nationwide investigation in Japan. Microbes Infect 2004; 6:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/40\">",
"      Darenberg J, Luca-Harari B, Jasir A, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007; 45:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8519/abstract/41\">",
"      Patel RA, Binns HJ, Shulman ST. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J Pediatr 2004; 144:68.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3169 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.10.40.232-7F6A7747C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8519=[""].join("\n");
var outline_f8_20_8519=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hemodynamic support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Surgical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Mechanisms of penicillin failure when used alone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Clindamycin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Empiric therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Tailored therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Adjunctive therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Intravenous immune globulin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Hyperbaric oxygen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Anti-TNF antibody",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3169\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3169|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/7/39036\" title=\"table 1\">",
"      Management strep TSS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6616?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42551?source=related_link\">",
"      Group A streptococcal (Streptococcus pyogenes) bacteremia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=related_link\">",
"      Hyperbaric oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=related_link\">",
"      Necrotizing soft tissue infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/35/40505?source=related_link\">",
"      Use of vasopressors and inotropes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_20_8520="Adoption";
var content_f8_20_8520=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"20\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Adoption",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8520/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8520/contributors\">",
"     Heidi Schwarzwald, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8520/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8520/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8520/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8520/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/20/8520/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although many families seek to adopt because of infertility, adoption also is common among families who desire more children or have experienced a fetal loss or the death of a child [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/1\">",
"     1",
"    </a>",
"    ]. Pediatric healthcare providers participate in the care of adopted children at several levels: by providing preadoption counseling to prospective adoptive parents, evaluating children after adoption, or providing ongoing care to adoptees [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The formal adoption of children within the United States is reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adoption is a legal mechanism that allows for full family membership and privileges to children who were not born into the family [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition to formal (legal) adoption, informal adoption occurs when the birth mother allows another person to take parental responsibility for her child without obtaining legal approval or recognition of that relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/4\">",
"     4",
"    </a>",
"    ]. Terms that are used commonly in adoption are defined below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Birth parent or biologic parent &ndash; The individuals who conceived the child; care should be taken not to refer to these individuals as the \"real\" parents",
"     </li>",
"     <li>",
"      Adoptive parent &ndash; The individual who is rearing the child",
"     </li>",
"     <li>",
"      Adoption triad &ndash; Birth parents, adoptive parents, and the adopted child",
"     </li>",
"     <li>",
"      Adoption plan &ndash; The decision to pursue the legal tasks required to relinquish parental rights to another individual; care should be taken not to refer to this process as \"giving up\" the child",
"     </li>",
"     <li>",
"      Referral &ndash; The time in the adoption process when the prospective family is given information concerning a prospective adoptee",
"     </li>",
"     <li>",
"      Finalization &ndash; Completion of the legal process that transfers parental rights to the adoptive parents; it generally occurs two to six months after the child has been placed with the adoptive parent(s)",
"     </li>",
"     <li>",
"      Dissolution &ndash; The legal process of relinquishing parental rights after an adoption has been finalized",
"     </li>",
"     <li>",
"      Disruption &ndash; The legal process of relinquishing parental rights before an adoption has been finalized",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Types of adoption",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Agency adoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adoption services traditionally have been provided by licensed public or private agencies that work to place children who are legally free for adoption.",
"   </p>",
"   <p>",
"    Agencies screen the adoptive families and homes to determine their suitability for adoption. The home study includes information regarding the parents' motivation for adoption, financial status, religious beliefs, employment, education, marriage, childrearing practices, and housing. The parents must provide copies of birth and marriage certificates, financial statements, letters of recommendation, and reports of physical and mental health from a clinician and psychiatrist. Police and FBI clearance also must be obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to performing the home study, agencies share medical and social information with the adoptive families and provide services to members of the adoption triad through the adjustment period and beyond [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/2\">",
"     2",
"    </a>",
"    ]. Agencies may have a consulting clinician available to offer advice if children manifest physical, emotional, or developmental problems. In addition, the agency can receive and relay new medical information from the birth parents to the adoptive parents (eg, regarding inherited disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Independent adoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adoptions can be arranged privately through clinicians, attorneys, or other facilitators [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/3\">",
"     3",
"    </a>",
"    ]. The regulation of independent adoptions varies by state, and the above-mentioned services may or may not be required [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/5\">",
"     5",
"    </a>",
"    ]. Independent adoption is not permitted in Connecticut, Delaware, and Massachusetts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Subsidized adoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;In subsidized adoption, adoptive families receive financial support (eg, monthly cash payments and Medicaid coverage) from the federal and state governments to assist in caring for the adopted child [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/6\">",
"     6",
"    </a>",
"    ]. Subsidized adoption has facilitated the adoption of children with special needs, whose medical and special educational expenses might otherwise deter an adoptive family. Most families that adopt children from foster care receive adoption subsidies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Open adoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;An open adoption is one in which the birth and adoptive parents interact during the adoption process [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/7\">",
"     7",
"    </a>",
"    ]. The degree of openness varies and usually is agreed upon by all of the involved parties, including the adoption agency and the adopted child if he or she is of appropriate age. Approximately 70 percent of domestic adoptions are open adoptions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/8\">",
"     8",
"    </a>",
"    ]. Many open adoptions are facilitated independently.",
"   </p>",
"   <p>",
"    Few data are available regarding the impact of open adoption on the members of the adoption triad [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/9\">",
"     9",
"    </a>",
"    ]. Advocates of open adoption argue that it helps the birth parents with grief and separation and diminishes the adoptee's identity crisis during adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Advocates for continuing closed adoptions believe that birth mothers who have continued contact with their children have more difficulty with grief and separation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/12\">",
"     12",
"    </a>",
"    ] and that open adoption is more difficult for the adoptive parents and young adopted children [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/7,11\">",
"     7,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Legal-risk adoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;In legal-risk adoption, the child is placed in foster care with parents who are interested in adopting the child if reunification with the birth parents is not possible [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/6\">",
"     6",
"    </a>",
"    ]. The legal adoption of the child cannot be guaranteed to the foster parents because of the continuing rights of the birth parents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/51/27448?source=see_link&amp;anchor=H14#H14\">",
"     \"Epidemiology of foster care placement and overview of the foster care system in the United States\", section on 'Birth parents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Confidentiality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controversy is ongoing regarding how to balance the privacy and anonymity of biologic parents and the \"right-to-know\" interest of the adoptee. The regulation of confidentiality is approached by individual states in one of four ways:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Confidential records",
"    </span>",
"    &nbsp;&mdash;&nbsp;The original birth certificate and adoption records are kept sealed by the courts and can be inspected only with court approval. This approach is used in a small and declining number of states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Open records",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult adoptees are given access to their adoption records or original birth certificate upon request and with no restrictions. This is the policy in an increasing number of states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Search and consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;An adoption agency or other intermediary investigates the location of one party at the request of another party who would like identifying information. The adoptee may petition the court to open the records if the biologic parent does not consent to release of the identifying information. This approach is used in approximately 25 percent of states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Mutual consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;In mutual-consent, voluntary adoption registries, information is maintained in a central file where adult adoptees, biologic parents, and, in some cases, adoptive parents register their names to give consent to release identifying information if it is requested by one of the other parties. Identifying information can be released only if all parties agree.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current trends in adoption include increasing numbers of international, transracial, special-needs, surrogate, same-sex, and single-parent adoptions, as well as increasing openness in adoption [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/3\">",
"     3",
"    </a>",
"    ]. These trends result from the shortage of healthy newborns available for placement, cultural changes, and increasing attempts to find permanent families for special-needs children in foster care.",
"   </p>",
"   <p>",
"    The number of families seeking to adopt is increasing as the number of infants available for adoption continues to decline [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/13\">",
"     13",
"    </a>",
"    ]. An estimated 3.3 adoption seekers exist for every actual adoption [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. In the United States, approximately 136,000 children are adopted annually [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/15\">",
"     15",
"    </a>",
"    ]. Approximately 40 percent of adoptions occurred through public child welfare agencies and 14 percent were intercountry adoptions. In the 2007 National Survey of Adoptive Parents, adoptive parents reported that 40 percent of adopted children in United States were of a different race, culture, or ethnicity than their adoptive parent(s) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 25 percent of the 408,400 children in foster care in the United States are eligible for adoption [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/17\">",
"     17",
"    </a>",
"    ]. Among those that are adopted, 53 percent are adopted by their former foster parents, 32 percent by relatives, and 15 percent by people unrelated to them [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/17\">",
"     17",
"    </a>",
"    ]. However, many of the children in the foster care system who are available for adoption are difficult to place in permanent homes because of certain special needs (eg, older children; children of color; children with physical, mental, or emotional problems; and children who are part of a sibling group) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/13/16602?source=see_link\">",
"     \"Comprehensive health care for children in foster care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Between 9 and 15 percent of adoptions end in disruption before legalization [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Adoptions at greatest risk for disruption or dissolution involve children who are older than three years of age (up to a 25 percent disruption rate), who have special needs (14 percent disruption rate), who have prolonged stays in foster care, or who have experienced previous dissolutions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/4,5,22-24\">",
"     4,5,22-24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MEDICAL EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Preadoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric healthcare providers may be asked to review information concerning the health of a prospective adoptive child. The clinician can advise the family regarding the type of information that will be needed to make an informed assessment of the child's health. Families typically seek information about the needs for long-term care and prognosis related to any medical problems, as well as the availability of medical and community resources.",
"   </p>",
"   <p>",
"    During the initial visit, the clinician should review all the medical records that are available, determine whether additional information should be sought by the family, discuss the medical issues that can be anticipated for the child based upon the information that is available (or not available, as the case may be), and provide guidance regarding the timing of the first appointment for the adopted child. The clinician also may take this opportunity to address the issues of transition for both the adoptive family and the adoptive child. Parents should be encouraged to educate themselves about ways they can ease the adjustment for everyone, and set realistic expectations of the changes to their family.",
"   </p>",
"   <p>",
"    Pediatric healthcare providers should be aware that some parents expect the guarantee of a \"perfect child\". They may request unnecessary tests and expect the pediatric healthcare provider to provide unrealistic predictions. The adoptive family cannot be guaranteed that their child will be free of future health problems any more than a birth family can be [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of the pediatric healthcare provider is not to judge the advisability of a proposed adoption. However, the pediatric healthcare provider should clearly and honestly apprise the prospective parents and the involved agency of any special health needs detected now or anticipated in the future [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/26\">",
"     26",
"    </a>",
"    ]. Most adopted children are healthy, even those who have high-risk histories [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/25,27\">",
"     25,27",
"    </a>",
"    ]. Pediatric healthcare providers should define and explain the risks to the family so that potential problems can be anticipated and treated expediently, but should take care not to create a \"vulnerable\" child [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/25\">",
"     25",
"    </a>",
"    ]. The pediatric healthcare provider can also assist with making sure that the proper social support systems are in place to help the family cope with externalizing behaviors or other adjustment issues as they arise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Newborns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Families who are adopting newborns should seek information about the health and ethnicity of the birth parents, the course of the pregnancy and delivery, and the results of screening tests that were performed during the pregnancy and after birth. The information should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maternal use of nicotine, alcohol, and licit or illicit drugs",
"     </li>",
"     <li>",
"      Pregnancy complications, including diabetes mellitus",
"     </li>",
"     <li>",
"      Family history of genetic conditions (including learning disabilities and attention disorders), mental illness, and intellectual disability (mental retardation)",
"     </li>",
"     <li>",
"      Gestational age and birth weight of the infant",
"     </li>",
"     <li>",
"      The presence of any congenital anomalies or signs of intrauterine infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This information usually is available for infants being placed within the United States, particularly in open adoptions. It should also be available through an adoption agency [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Foster care children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical information for children who are being placed from foster care may be disjointed, fragmented, and difficult to obtain if they have lived in more than one foster care home and have had multiple healthcare providers. Many children in the foster care system have chronic medical problems, developmental or learning disabilities, and emotional problems. Obtaining as much information as possible regarding these children is important. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/13/16602?source=see_link&amp;anchor=H2#H2\">",
"     \"Comprehensive health care for children in foster care\", section on 'Health needs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who are adopted from the foster care system may have a history of physical abuse or neglect, poverty, malnutrition, inadequate stimulation, deficient interpersonal nurturing, intrauterine infection,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    drug or alcohol exposure, all of which can contribute to developmental delay and cognitive, emotional, and behavioral problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Two studies from the United Kingdom highlight the importance of having a multidisciplinary team in place for families completing adoption from foster care. In one study of 130 children followed longitudinally, all but three birth families had histories of abuse, neglect,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    time in state care [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/30\">",
"     30",
"    </a>",
"    ]. Another longitudinal study of 99 children found four factors that contributed independently to disruption: older age at placement; rejection by birth parents singly (when biologic siblings were NOT rejected); length of time in state care; and a high level of behavioral problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/31\">",
"     31",
"    </a>",
"    ]. Multiple previous placements was also a risk factor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Postadoption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adopted children often are scheduled to see the pediatric healthcare provider soon after placement within an adoptive family. This visit typically occurs within 7 to 10 days of the child's placement. The major purpose of this visit is to evaluate the presence of medical conditions that require treatment or pose a health risk to the adoptive family. The pediatric healthcare provider will need to assess the completeness of records and assess the presence of both acute and chronic medical problems if he or she has not already had the opportunity to do so.",
"   </p>",
"   <p>",
"    In addition, the pediatric healthcare provider should plan to spend additional time to educate the adoptive family regarding the physical, nutritional, safety, developmental, social, and emotional needs of their child. This information is particularly important for first-time parents who adopt older children and have not received the anticipatory guidance, parenting, and safety advice that is provided at regularly scheduled health maintenance visits [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The social history should include the following questions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      What is the family structure?",
"     </li>",
"     <li>",
"      Who are the primary caregivers?",
"     </li>",
"     <li>",
"      How does the child spend his or her day?",
"     </li>",
"     <li>",
"      Have there been any stresses in the home?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All children should have a complete medical evaluation that includes assessment of growth and development, physical examination, age-appropriate screening tests, and assessment of immunization status. Newborn screening tests should be repeated if they are indicated by the child's age or assessment and the original results cannot be confirmed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link\">",
"     \"Standard immunizations for children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43225?source=see_link&amp;anchor=H7#H7\">",
"     \"Screening tests in children and adolescents\", section on 'Common screening tests in pediatrics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Mental health issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older infants and children who are adopted may have a history of emotional deprivation, physical or sexual abuse, or other adverse caregiver experiences that may predispose them to long-term psychologic problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/18,28\">",
"     18,28",
"    </a>",
"    ]. The adoptive parents of these children should be counseled regarding the special needs of children who come from such circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/26,32\">",
"     26,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The emotional climate of the previous home and the child's experiences with the previous caregiver should be reviewed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, a review of development and an assessment of behavior should be part of the evaluation. Referral to a child psychologist or psychiatrist should be made if problems are identified in these areas, and a plan for ongoing treatment and follow-up should be developed.",
"   </p>",
"   <p>",
"    Adolescents, in particular, should be screened for emotional and psychologic problems. Univariate analysis of data from a subset of adolescents in the National Longitudinal Study of Adolescent Health indicated that adopted adolescents were more likely to have attempted suicide (7.6 versus 3.1 percent) and to have received psychologic or emotional counseling (16.9 versus 8.2 percent) in the past year than had their nonadopted peers [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23834?source=see_link\">",
"     \"Suicidal behavior in children and adolescents: Epidemiology and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Special-needs children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adopted children who have physical and mental handicaps probably have experienced multiple traumas and frustrations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/25\">",
"     25",
"    </a>",
"    ]. They may have limited coping skills to deal with their feelings of rejection or deprivation. The pediatric healthcare provider can help both the child and the adoptive family address these issues by making appropriate referrals for counseling, support groups, special education, and financial aid.",
"   </p>",
"   <p>",
"    Families who adopt special-needs children through state social service agencies may be eligible for financial assistance from the federal Title IV-E adoption assistance program and additional subsidy programs that vary from state to state [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/26\">",
"     26",
"    </a>",
"    ]. Applications for subsidy programs are accepted only at the time of adoption. Thus, families should be encouraged to discuss these programs with their case workers and to apply for financial assistance even if no perceived need exists at the time of adoption, because special-needs children may require long-term therapy for problems that were not anticipated based upon the initial evaluations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DEVELOPMENTAL STAGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adoption is a lifelong process; particular questions, concerns, and emotional issues related to adoption emerge for the adopted child and adoptive parents at various developmental stages [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]. Pediatric healthcare providers can help the families anticipate and prepare for these specific adoption-related problems and may want to consider increasing the duration of appointments for adoptees to address these special concerns. Resources related to adoption are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef65533 \" href=\"UTD.htm?20/52/21323\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Before the adoption, adoptive parents may experience a mixture of emotions, including grief and loss, happiness, and anxiety regarding their ability to parent the adopted child. They also must decide how to integrate the child into their existing family structure and prepare answers to the questions that the child or other family members will ask about the adoption.",
"   </p>",
"   <p>",
"    Preschool children will begin to ask questions about their histories. They may begin to have magical thoughts about people or places in their past and may notice ethnic differences. Racial and ethnic differences should be discussed openly and regarded as a source of family enrichment. The child's need to identify with his or her ethnic group must be respected and facilitated as the child grows [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34\">",
"     32,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    School-age children may not want to talk about their adoption, but they will think about it and be particularly concerned about the permanency of the arrangement [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Issues of identity develop during adolescence. Adolescents may idealize the birth family and begin to express a need to search for birth relatives [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. This search for biologic identity is not a rejection of the adoptive family but a normal developmental stage. Addressing the adoptee's wishes may improve the adoptee's sense of identity, long-term adjustment, and relationship with the adoptive parents [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DISCLOSURE PROCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children who are adopted should know that they are adopted [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/3\">",
"     3",
"    </a>",
"    ]. The revelation process should take place gradually and can span a considerable period [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34,35,40\">",
"     32,34,35,40",
"    </a>",
"    ]. This ongoing discussion about adoption in parent-child interactions replaces the previous notion of telling the child at a specific point in time [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34\">",
"     32,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric healthcare providers should encourage open discussion of adoption and adoption terminology. They should not inadvertently reinforce a family's perceived need for secrecy. Keeping adoption a secret from the child implies that being adopted is a negative condition that should not be discussed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/34\">",
"     34",
"    </a>",
"    ]. Discovery or disclosure of adoption when the child is older may lead to mistrust, insecurity, and anger.",
"   </p>",
"   <p>",
"    Parents should be encouraged to use the words \"adoption\" and \"adopted\" in a warm and positive manner, even before the child understands what they mean. Developmentally appropriate information should be provided to the child with love and respect in an open, matter-of-fact manner [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]. The information may need to be repeated and modified depending upon the child's emotional reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parents should be comfortable speaking freely about their family's origins. They should be guided by the child's questions, answering truthfully and expanding their explanations if the child indicates that he or she wants to hear more [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34,36\">",
"     32,34,36",
"    </a>",
"    ]. Parents should be alert for opportunities for open discussion about the child's birth, birth parents, and adoption. Older children, who may be reluctant to discuss their concerns, may need to be encouraged through direct questions or statements.",
"   </p>",
"   <p>",
"    Children who are in elementary school may ask specific questions about their birth or adoption. Their questions should be answered honestly, emphasizing that the decision was made in the best interest of the child. Adoptive parents should be warned that implying that the child was \"chosen\" may make the child worry about rejection (ie, being \"unchosen\") or feel undue burden to perform [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]. Assuring the child regarding the permanence of the arrangement when he or she is between the ages of 8 and 10 years is particularly important because children of these ages, even those who live with their birth parents, have concerns about permanency [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     LONG-TERM OUTCOMES IN CHILDREN ADOPTED DOMESTICALLY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are studies from other developed countries and studies that focus on children who have been adopted from institutions within their own countries, there are few prospective, long-term studies of children adopted domestically in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Information from these studies is summarized below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the National Longitudinal Study of Adolescent Health, the psychologic adjustment and physical health of adoptees and non-adopted children did not differ. However, adopted adolescents reported less academic success and more learning disabilities, and female adoptees reported less closeness to their mothers than female nonadoptees [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children placed in a permanent home at a younger age have fewer long-term developmental and psychologic needs [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Studies on long-term outcomes of transracial adoptions remain small and seemingly indicate that self-esteem and self-identity are not affected, but this remains controversial [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/44,45\">",
"       44,45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ROLE OF CLINICIAN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adoption is not an isolated event but a lifelong process for the parents and the child. Pediatric healthcare providers can help a child accept his or her adoption by helping the family feel good about being adoptive parents. Parents who are struggling with unresolved adoption issues may have difficulty discussing adoption with their children. Pediatric healthcare providers may encourage these parents to seek counseling through the adoption agency or a community support group [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All members of the adoptive family may need help in responding to questions or statements about the status of the adopted child. Being able to discuss these questions openly with their pediatric healthcare provider helps children understand and accept their adoptive status [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/32,34\">",
"     32,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics (AAP) Committee on Early Childhood, Adoption, and Dependent Care policy statement on the role of the pediatric healthcare provider in issues of confidentiality in adoption makes the following recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric healthcare providers should serve as their patients' advocates in all issues related to adoption.",
"     </li>",
"     <li>",
"      The pediatric healthcare provider should counsel the adoptee and the adoptive family throughout childhood in anticipation of and in response to different issues. This counseling is particularly important as adoptees become curious about their biologic identity.",
"     </li>",
"     <li>",
"      Pediatric healthcare providers should be familiar with the laws of their states regarding confidentiality or be able to make a referral to appropriate sources of information [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8520/abstract/39\">",
"       39",
"      </a>",
"      ]. They should know the state laws regarding open adoption, how open adoptions are monitored, and whether the involvement of a professional adoption specialist is required. They also should know whether a mutual consent registry exists and, if so, how it functions and whether counseling is provided to adoptees who seek information from the registry.",
"     </li>",
"     <li>",
"      Pediatric healthcare providers should be familiar with local support groups and referral resources that address adoption issues. They should be able to make appropriate social service or mental health referrals as indicated for any member of an adoption triad.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adoption is a legal mechanism that allows for full family membership and privileges to children who were not born into the family. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During preadoption visits, the pediatric healthcare provider should clearly and honestly apprise the prospective parents and the involved agency of any special health needs detected or anticipated in the future. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Preadoption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major purpose of the first postadoption visit is to evaluate the presence of medical conditions that require treatment or pose a health risk to the adoptive family. The healthcare provider also should educate the adoptive family about the physical, nutritional, safety, developmental, social, and emotional needs of their child. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Postadoption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Older infants and children who have been adopted should be screened for emotional and psychologic problems. The adoptive parents should be counseled regarding the special needs of adoptive children related to the adverse life experiences that made them eligible for adoption. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Mental health issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pediatric healthcare provider should provide referrals as indicated for counseling, support groups, special education services, and financial aid. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Special-needs children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adoption is a lifelong process; particular questions, concerns, and emotional issues related to adoption emerge for the adopted child and adoptive parents at various developmental stages. Pediatric healthcare providers can help the families anticipate and prepare for these specific adoption-related issues. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Developmental stages'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The process of telling the child that he or she was adopted should take place gradually. Open discussion of adoption is encouraged. Developmentally appropriate information should be provided to the child with love and respect in an open, matter-of-fact manner. The information may need to be repeated and modified depending upon the child's emotional reaction. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Disclosure process'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pediatric healthcare providers should be familiar with the laws of their states regarding confidentiality or be able to make a referral to appropriate sources of information. They also should be familiar with local support groups and referral resources that address adoption issues (",
"      <a class=\"graphic graphic_table graphicRef65533 \" href=\"UTD.htm?20/52/21323\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Role of clinician'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/1\">",
"      Bachrach CA, London KA, Maza PL. On the path to adoption: Adoption seeking in the United States, 1988. J Marriage Fam 1991; 53:705.",
"     </a>",
"    </li>",
"    <li>",
"     Miller LC. Adoption. In: Oski's Pediatrics: Principles and Practice, 4th ed, McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.835.",
"    </li>",
"    <li>",
"     Miller LC. Adoption and foster family care. In: Developmental-Behavioral Pediatrics, 4th, Carey WB, Crocker AC, Coleman WL, et al.  (Eds), Saunders Elsevier, Philadelphia 2009. p.134.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/4\">",
"      Stolley KS. Statistics on adoption in the United States. Future Child 1993; 3:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/5\">",
"      Groze V. Special needs adoption. Child Youth Serv Rev 1986; 8:363.",
"     </a>",
"    </li>",
"    <li>",
"     Child Welfare Information Gateway Glossary. Available at: www.childwelfare.gov/admin/glossary/index.cfm (Accessed on January 24, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/7\">",
"      American Academy of Pediatrics Committee on Early Childhood, Adoption, and Dependent Care: Issues of confidentiality in adoption: the role of the pediatrician. Pediatrics 1994; 93:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/8\">",
"      Berry M. Adoptive parents' perceptions of, and comfort with, open adoption. Child Welfare 1993; 72:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/9\">",
"      Curtis PA. The dialectics of open versus closed adoption of infants. Child Welfare 1986; 65:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/10\">",
"      Pannor R, Baran A. Open adoption as standard practice. Child Welfare 1984; 63:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/11\">",
"      Berry M. Risks and benefits of open adoption. Future Child 1993; 3:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/12\">",
"      Blanton TL, Deschner J. Biological mothers' grief: the postadoptive experience in open versus confidential adoption. Child Welfare 1990; 69:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/13\">",
"      Bachrach CA, Stolley KS, London KA. Relinquishment of premarital births: evidence from national survey data. Fam Plann Perspect 1992; 24:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/14\">",
"      Freundlich M. Supply and demand: The forces shaping the future of infant adoptions. Adoption Quarterly 1998; 2:13.",
"     </a>",
"    </li>",
"    <li>",
"     Child Welfare Information Gateway (2011). How many children were adopted in 2007 and 2008? www.childwelfare.gov/pubs/adopted0708.pdf (Accessed on January 24, 2012).",
"    </li>",
"    <li>",
"     Vandivere S, Malm K, Radel L. Race, ethnicity, and gender. In: Adoption USA: A Chartbook Based on the 2007 National Survey of Adoptive Parents, The US Department of Health and Human Services, Washington, DC 2009. p.13.",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. The AFCARS Report (Preliminary FY 2010 estimates). Available at: www.acf.hhs.gov/programs/cb/stats_research/afcars/tar/report18.pdf (Accessed on January 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/18\">",
"      McKenzie JK. Adoption of children with special needs. Future Child 1993; 3:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/19\">",
"      Rosenthal JA. Outcomes of adoption of children with special needs. Future Child 1993; 3:77.",
"     </a>",
"    </li>",
"    <li>",
"     Nutman TB, Kazura J, Kettenring JR, Wheeler W. The shadow of success: A statistical analysis of outcomes of adoptions of hard-to-place children, Spaulding for Children, Westfield, NJ 1984.",
"    </li>",
"    <li>",
"     Groza V, Rosenberg K. Clinical and practice issues in adoption: Bridging the gap between adoptees placed as infants and as older children, Praeger, Westport, CT 1998.",
"    </li>",
"    <li>",
"     Child Welfare Information Gateway. Adoption disruption and dissolution. December, 2004. Available at: www.childwelfare.gov/pubs/s_disrup.pdf (Accessed on January 30, 2012).",
"    </li>",
"    <li>",
"     Barth RP, Berry M. Adoption and disruption: Rates, risks, and responses, Whittaker JK (Ed), Adline Transaction, Hawthorne, NY 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/24\">",
"      Festinger T. After adoption: dissolution or permanence? Child Welfare 2002; 81:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/25\">",
"      Haberkern RC. Adoption: new tasks for the pediatrician. Pediatr Rev 1988; 10:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/26\">",
"      Jones VF, Committee On Early Childhood, Adoption, And Dependent Care. Comprehensive health evaluation of the newly adopted child. Pediatrics 2012; 129:e214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/27\">",
"      Brand AE, Brinich PM. Behavior problems and mental health contacts in adopted, foster, and nonadopted children. J Child Psychol Psychiatry 1999; 40:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/28\">",
"      Simmel C, Brooks D, Barth RP, Hinshaw SP. Externalizing symptomatology among adoptive youth: prevalence and preadoption risk factors. J Abnorm Child Psychol 2001; 29:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/29\">",
"      Brodzinsky DM, Steiger C. Prevalence of adoptees among special education populations. J Learn Disabil 1991; 24:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/30\">",
"      Rees CA, Selwyn J. Non-infant adoption from care: lessons for safeguarding children. Child Care Health Dev 2009; 35:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/31\">",
"      Rushton A, Dance C. The adoption of children from public care: a prospective study of outcome in adolescence. J Am Acad Child Adolesc Psychiatry 2006; 45:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/32\">",
"      Borchers D, American Academy of Pediatrics Committee on Early Childhood, Adoption, and Dependent Care. Families and adoption: the pediatrician's role in supporting communication. Pediatrics 2003; 112:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/33\">",
"      Slap G, Goodman E, Huang B. Adoption as a risk factor for attempted suicide during adolescence. Pediatrics 2001; 108:E30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/34\">",
"      Jones VF, Schulte EE, Committee on Early Childhood, Council on Foster Care, Adoption, and Kinship Care. The pediatrician's role in supporting adoptive families. Pediatrics 2012; 130:e1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/35\">",
"      Brodzinsky DM, Singer LM, Braff AM. Children's understanding of adoption. Child Dev 1984; 55:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/36\">",
"      Hersov L. The Seventh Jack Tizard Memorial Lecture. Aspects of adoption. J Child Psychol Psychiatry 1990; 31:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/37\">",
"      Schwartz EM. Problems after adoption: some guidelines for pediatrician involvement. J Pediatr 1975; 87:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/38\">",
"      Rosenberg EB, Horner TM. Birthparent romances and identity formation in adopted children. Am J Orthopsychiatry 1991; 61:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/39\">",
"      Committee on Adoption and Dependent Care. The role of the pediatrician in adoption with reference to 'the right to know': an update. Pediatrics 1981; 67:305.",
"     </a>",
"    </li>",
"    <li>",
"     Dewoody M. Adoption and Disclosure: A Review of the Law, Child Welfare League of America, Washington, DC 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/41\">",
"      Schechter MD, Holter FR. Adopted children in their adoptive families. Pediatr Clin North Am 1975; 22:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/42\">",
"      Burrow AL, Tubman JG, Finley GE. Adolescent adjustment in a nationally collected sample: identifying group differences by adoption status, adoption subtype, developmental stage and gender. J Adolesc 2004; 27:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/43\">",
"      Nickman SL, Rosenfeld AA, Fine P, et al. Children in adoptive families: overview and update. J Am Acad Child Adolesc Psychiatry 2005; 44:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/44\">",
"      Burrow AL, Finley GE. Transracial, same-race adoptions, and the need for multiple measures of adolescent adjustment. Am J Orthopsychiatry 2004; 74:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8520/abstract/45\">",
"      Vroegh KS. Transracial adoptees: developmental status after 17 years. Am J Orthopsychiatry 1997; 67:568.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2854 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-4838B967EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8520=[""].join("\n");
var outline_f8_20_8520=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Types of adoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Agency adoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Independent adoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Subsidized adoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Open adoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Legal-risk adoption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Confidentiality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Confidential records",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Open records",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Search and consent",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Mutual consent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MEDICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Preadoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Newborns",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Foster care children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Postadoption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Mental health issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Special-needs children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DEVELOPMENTAL STAGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DISCLOSURE PROCESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      LONG-TERM OUTCOMES IN CHILDREN ADOPTED DOMESTICALLY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ROLE OF CLINICIAN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2854\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2854|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/52/21323\" title=\"table 1\">",
"      Adoption resources",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/13/16602?source=related_link\">",
"      Comprehensive health care for children in foster care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/51/27448?source=related_link\">",
"      Epidemiology of foster care placement and overview of the foster care system in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43225?source=related_link\">",
"      Screening tests in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23834?source=related_link\">",
"      Suicidal behavior in children and adolescents: Epidemiology and risk factors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_20_8521="Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons";
var content_f8_20_8521=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8521/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8521/contributors\">",
"     John F Beary, III, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8521/contributors\">",
"     Arkadi A Chines, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8521/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8521/contributors\">",
"     Richard D Zane, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/20/8521/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/20/8521/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/20/8521/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential actions by terrorist groups span the NBC (nuclear, biological, chemical) threat spectrum. This topic discusses chemical warfare and chemical terrorism and reviews the medical aspects of detecting, diagnosing, and treating patients exposed to the chemical agents that are most likely to be used by terrorists as well as the appropriate initial actions to be taken by those exposed to such agents. Nuclear terrorism is beyond the scope of this topic, but practical information can be found elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Bioterrorism is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=see_link\">",
"     \"Identifying and managing casualties of biological terrorism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;The word terrorism was first used to describe the post-revolutionary French \"reign of terror\" of 1793 to 1794. The term is now applied to NBC releases and other actions that violate international law, and which seek to intimidate, demoralize, or subjugate a population for political, religious, or ideological purposes. The use of biological and chemical weapons violates international law and is governed by treaties administered by the United Nations (UN). The biological weapons treaty was opened for signature in April 1972 and went into force in March 1975. The chemical weapons treaty was adopted in Geneva in September 1992 and went into force in April 1997. The Chemical Weapons Convention is administered in The Hague, Netherlands.",
"   </p>",
"   <p>",
"    Research into biologic markers of exposure to chemical weapons is making steady progress and is important because of the need for rapid and reliable diagnosis of the chemical agents used in a terrorist attack, the need to confirm nonexposure for worried individuals, and the ability to document noncompliance with the UN Chemical Weapons Convention treaty [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 423 BC, a toxic smoke (sulfur and pitch) was used by the Spartan allies in the Peloponnesian War to force their enemies to abandon a fortification.",
"     </li>",
"     <li>",
"      The first modern use of chemical warfare (CWF) was on April 22, 1915 near Ypres, Belgium, where the Germans dispersed 150 tons of chlorine gas from about 6000 cylinders, generating 5000 pulmonary casualties among the 15,000 Allied troops on the battlefield.",
"     </li>",
"     <li>",
"      Sarin, the prototypical nerve agent and most significant current chemical terror threat, was synthesized in 1937 by Dr Gerhard Schrader of IG Farbenindustrie, Leverkusen Germany as part of the Nazi preparations for World War II. However, nerve agents were not used against the Allies because of fear of retaliation in kind.",
"     </li>",
"     <li>",
"      In 1983 Iraq used tabun against Iran, and Iran responded with a nerve agent of unidentified type. This exchange generated at least 10,000 deaths and casualties in the two armies.",
"     </li>",
"     <li>",
"      On March 16,1988, Iraq launched an attack on the Kurd population of Halabja, Iraq where there were 5000 deaths and a high number of casualties from both sarin and from sulfur mustard.",
"     </li>",
"     <li>",
"      A 1995 Tokyo subway attack by the religious cult Aum Shinrykio utilized sarin and caused 12 deaths and 5000 casualties [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/4\">",
"       4",
"      </a>",
"      ]. One year earlier, the cult had conducted a test attack on an apartment building in Japan and killed seven people.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TYPES OF CHEMICAL AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve agents, toxic asphyxiants, pulmonary irritants, and blistering agents are the major types of chemical weapons potentially available to terrorists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nerve agents (cholinesterase inhibitors)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prototypical nerve agent is sarin. These organophosphate esters are generally colorless, odorless, and tasteless agents that do not irritate the skin. They are hazardous in liquid, vapor, and aerosol forms. Exposure can occur via the lungs, skin, or eyes. Nerve agent weapons are transported in liquid form and transform into gas upon release due to their volatility. In addition to sarin, agents such as VX (oily liquid) and tabun (clear liquid) are also potentially available to terrorists.",
"   </p>",
"   <p>",
"    Variants of nerve agents are used as insecticides in agricultural applications. An agricultural exposure, however, typically presents with slower symptom onset and requires supportive treatment for extended periods of time, whereas recovery will be quicker if a nerve agent patient survives for two or three days.",
"   </p>",
"   <p>",
"    The mechanism of action of nerve agents is inhibition of cholinesterase, which produces a state of acetylcholine excess [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/5\">",
"     5",
"    </a>",
"    ]. The resulting excessive cholinergic activity produces severe secretions from many sites and stimulation of smooth muscle. Nerve agents inhibit nerve transmission in skeletal muscle; this affects respiratory muscles and causes respiratory failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Toxic asphyxiants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prototypical toxic asphyxiant is cyanide (hydrocyanic acid, HCN). It is a colorless liquid or gas that smells like almonds. Arsine (arsenic trihydride) is another agent in this class. Cyanide has multiple industrial uses including the fumigation of ships and buildings, electroplating and metal cleaning, and use as a rodenticide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/18/7466?source=see_link\">",
"     \"Cyanide poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism of action of cyanide poisoning is reaction with the trivalent iron of cytochrome oxidase in the mitochondria. Cellular respiration is thus inhibited, resulting in lactic acidosis and cytotoxic hypoxia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pulmonary irritants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prototypical pulmonary irritant is phosgene, a common industrial chemical. It is a colorless liquid that when exposed to air gives off a gas that smells like newly mown hay. Chlorine and ammonia are other agents in this class that can generate casualties from industrial accidents or from terrorist acts.",
"   </p>",
"   <p>",
"    The mechanism of action of these irritant agents is direct lung tissue injury, with subsequent pulmonary edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Blister agents (vesicants)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prototypical blister agent is sulfur mustard. It is a brown oily liquid at room temperature that converts to a gas with weapon system delivery. It smells like garlic or onions. Toxicity to the eyes, skin, and lungs occurs via direct contact with the toxic substance. Lewisite is another agent in this class. It is more difficult to handle and transport, but there is a possibility of terrorist use. These agents have no industrial applications. They are also carcinogens.",
"   </p>",
"   <p>",
"    The mechanism of action of blister agents is interference with DNA synthesis and with cell division [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/6\">",
"     6",
"    </a>",
"    ]. In cancer therapeutics, the related compounds are known as alkylating agents and include nitrogen mustard (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/57/40853?source=see_link\">",
"     mechlorethamine",
"    </a>",
"    ), the structurally related alkylating agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , and alkyl sulfonate (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/10/10408?source=see_link\">",
"     busulfan",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF CHEMICAL AGENT EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signature of a chemical weapon release is the sudden onset of symptoms within minutes, in the context of mass casualties (",
"    <a class=\"graphic graphic_table graphicRef62267 \" href=\"UTD.htm?9/9/9374\">",
"     table 1",
"    </a>",
"    ). In contrast, bioweapon release may take many hours or days to become apparent. Biologic weapon syndromes are also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=see_link\">",
"     \"Identifying and managing casualties of biological terrorism\"",
"    </a>",
"    .) Certain types of intentional uses of nonweaponized chemical agents might be more difficult to detect, if the initial symptoms are absent or mild despite long-term health effects (eg, dimethyl mercury) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The main syndromes that suggest terrorist release of chemical weapons are neurologic, pulmonary, and skin and eye symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neurologic symptoms",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immediate",
"      <span class=\"nowrap\">",
"       symptoms/large",
"      </span>",
"      numbers of patients: Nerve agents; cyanide (seizures; coma).",
"     </li>",
"     <li>",
"      Delayed symptoms: Botulism (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link\">",
"       \"Botulism\"",
"      </a>",
"      ); encephalitis agents.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pulmonary symptoms",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immediate",
"      <span class=\"nowrap\">",
"       symptoms/large",
"      </span>",
"      numbers: Sulfur mustard; phosgene; cyanide; nerve agent.",
"     </li>",
"     <li>",
"      Slower onset",
"      <span class=\"nowrap\">",
"       symptoms/unusual",
"      </span>",
"      clusters: Anthrax (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7224?source=see_link\">",
"       \"Clinical manifestations and diagnosis of anthrax\"",
"      </a>",
"      ); plague (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"      </a>",
"      ); staphylococcal enterotoxin B (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=see_link\">",
"       \"Differential diagnosis of microbial foodborne disease\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Skin and eye burns",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immediate",
"      <span class=\"nowrap\">",
"       symptoms/large",
"      </span>",
"      numbers: Blister agents such as sulfur mustard.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Rash",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A rash suggests exposure to a biologic agent. Smallpox (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/61/35797?source=see_link\">",
"       \"The epidemiology, pathogenesis, and clinical manifestations of smallpox\"",
"      </a>",
"      ), anthrax (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7224?source=see_link\">",
"       \"Clinical manifestations and diagnosis of anthrax\"",
"      </a>",
"      ), plague (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"      </a>",
"      ), viral hemorrhagic fever (eg, Ebola) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40121?source=see_link\">",
"       \"Diseases potentially acquired by travel to sub-Saharan Africa\"",
"      </a>",
"      ), and T2-mycotoxin should be considered.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Gastrointestinal bleeding",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A biologic agent should be considered. Examples are anthrax (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7224?source=see_link\">",
"       \"Clinical manifestations and diagnosis of anthrax\"",
"      </a>",
"      ), ricin, viral hemorrhagic fever agents (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40121?source=see_link\">",
"       \"Diseases potentially acquired by travel to sub-Saharan Africa\"",
"      </a>",
"      ), and T2-mycotoxin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Fever",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suggests a bioweapon attack, particularly when an endemic disease appears at an unusual time or pattern. Patients presenting with relatively uncommon diseases with terrorist interest (such as anthrax or plague) should raise suspicion for a bioweapon attack.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PROTECTION OF RESPONDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The basic principles of self-protection are taught to all first responders in civilian and military settings. It is inappropriate for responders to enter a situation until and unless they can do so without endangering themselves. Therefore, first response units organized to respond to chemical agent exposure must be equipped with appropriate protective clothing and equipment. A wide variety of boots, gloves, coveralls, masks, and breathing apparatus are available. Standards have been established by the National Fire Protection Association, and these can be consulted via the Association's web page (",
"    <a class=\"external\" href=\"file://www.nfpa.org/\">",
"     www.nfpa.org",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    It is also inappropriate to bring patients who are not decontaminated to first receiving facilities (hospitals and emergency departments). If contaminated patients are permitted within such facilities, they endanger staff and the capacity of the health care system to manage the chemical exposure incident.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     NERVE AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve agents include sarin, tabun, and VX.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acetylcholine accumulation results in excess cholinergic activity, which produces smooth muscle constriction, profuse secretions, small pupils and related visual disturbance [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/5\">",
"     5",
"    </a>",
"    ]. Skeletal muscle weakness also results, which can lead to respiratory failure and death. Nerve agent toxicity can be remembered as the \"runny nose, crying, drooling, defecating, urinating, and vomiting\" type of poisoning, reflecting the severe stimulus for multiple body secretions and increased smooth muscle motility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Actions if exposed",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms (described above) can begin in seconds to minutes depending upon the extent of exposure. Death can occur in 1 to 10 minutes. If a liquid agent is splashed on the skin, it could take as long as 30 minutes before symptoms commence. Those exposed to nerve agent should:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leave the exposure area at once, and head to fresh air. Remember that nerve gas vapors are heavier than air and tend to settle; therefore, do not lay down and do not remain in below-ground spaces. Cover the nose and mouth with a wet cloth if possible. Remain calm and try not to inhale until you are away from the exposure area. Take shallow breaths only if you must. Gas masks are not recommended unless the person is trained in their use. Incorrect use of such masks has caused fatalities.",
"     </li>",
"     <li>",
"      Seek treatment with antidotes (see below)",
"      <strong>",
"       at once.",
"      </strong>",
"     </li>",
"     <li>",
"      Undergo decontamination. Remove all clothing and all jewelry, which should be placed in sealed double plastic bags. Shower immediately with soap and water. Also, flush the eyes with water for five to ten minutes because nerve agents can enter via the ocular route as well as via the skin. Wash clothing with bleach.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Medical decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decontamination of nerve agents can be assisted with topical products [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. On July 31, 2003, the FDA approved a new chemical warfare decontamination lotion for use by military and civilian emergency services personnel. The product is called RSDL (Reactive Skin Decontamination Lotion), and it acts within seconds of being applied to the skin (",
"    <a class=\"external\" href=\"file://www.fda.gov/\">",
"     www.fda.gov/",
"    </a>",
"    ). It neutralizes the toxicity of nerve and blister agents by breaking down these molecules. The lotion is specifically active against the liquid nerve agent VX and blister agents such as mustard and Lewisite. It may also be suitable for skin decontamination of biologic agents such as anthrax, and research results should soon be available to provide guidance.",
"   </p>",
"   <p>",
"    The lotion is packaged on a foam applicator inside a single use pouch. The lotion is applied within three minutes of contamination, and the non-toxic residue is washed away at a later time.",
"   </p>",
"   <p>",
"    RSDL was used in the 1991 Gulf War. Current research protocols are also testing the product for application to the entire body, including the eyes, nose, and mouth. The early use of RSDL will be by emergency response personnel, but one can anticipate wider labeled use of the product as experience is gained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Medical management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of treatment are to antagonize excess acetylcholine (ACh), restore function of the anticholinesterase enzyme to break down Ach, and general medical management of complications such as respiratory failure and seizures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33176?source=see_link\">",
"     \"Organophosphate and carbamate poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Atropine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    will antagonize the ACh actions at muscarinic receptor sites including salivation, tracheobronchial secretion and bronchoconstriction, bradycardia, and to a moderate extent the central actions of ACh excess state. Atropine has little effect on the peripheral neuromuscular compromise.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    should be given in doses that will cross the blood-brain barrier. The initial injection should be 2 to 4 mg, given intravenously if possible [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/8\">",
"     8",
"    </a>",
"    ]. However, in a mass casualty situation, giving the drug intramuscularly (IM) will be more practical. Atropine is re-dosed at 2 mg IM every 5 to 10 minutes until muscarinic symptoms disappear. More than 200 mg of atropine may be required in the first 24 hours for nerve agent poisoning. In contrast, the organophosphorus insecticides used in agriculture have a slower onset of symptoms but a much longer duration of action, such that these patients may need thousands of milligrams of atropine to recover. Finally, a mild degree of atropine block should be maintained on day two and day three after exposure or as long as muscarinic symptoms are present.",
"   </p>",
"   <p>",
"    On June 20, 2003, the United States FDA approved the following dosages of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    in children and adolescents with mild symptoms of nerve agent or insecticide poisoning: 0.5 mg for children between 15 to 40 pounds; 1 mg for children between 40 to 90 pounds; and 2 mg for adults and children weighing over 90 pounds [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/10\">",
"     10",
"    </a>",
"    ]. For children with severe symptoms, amounts up to three times these doses may be given.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Pralidoxime",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/8/16517?source=see_link\">",
"     Pralidoxime",
"    </a>",
"    , also known as 2-PAM, is a cholinesterase reactivator of the oxime pharmacologic class, and it is directed at the same enzyme target that nerve poisons seek to harm. The adult dose of pralidoxime is 1 to 2 g given intravenously within five minutes of presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Children under 40 kg may receive an intravenous dose of 20 to 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    (maximum single dose 2 g). If weakness is not relieved or recurs after 20 to 60 minutes, the dose should be repeated. Severely poisoned patients (ie, altered mental status, coma, seizures, severe respiratory depression, or severe muscle weakness) may benefit from a continuous pralidoxime infusion (8",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per hour in adults or 10 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per hour in children (under 40 kg)) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/11\">",
"     11",
"    </a>",
"    ]. Early treatment is important so that the drug can reach the phosphorylated enzyme in time to reactivate it. Agricultural experience has shown that some nerve agents are quite lipid soluble and will partition into body fat resulting in persistent toxicity that may require treatment for several weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33176?source=see_link\">",
"     \"Organophosphate and carbamate poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a mass casualty situation, intravenous access may not be practical.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/8/16517?source=see_link\">",
"     Pralidoxime",
"    </a>",
"    may be administered IM into a large muscle such as the quadriceps. Pralidoxime is available in auto-injector kits used by the military and also available to medical first responders. The auto-injectors deliver an IM dose of 600 mg. Depending upon the severity of the exposure, adult doses of 600 or 1800 mg IM may be appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. In children under 40 kg, intramuscular dosing is 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose up to three doses. However, the need to draw up pralidoxime to administer this dose is problematic in a mass casualty scenario. Dosing guidelines that utilize the Mark I autoinjector have been suggested for children with severe exposures as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximate weight 13 to 25 kg: 1 autoinjector (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      dose range 0.08 to 0.13",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/8/16517?source=see_link\">",
"       pralidoxime",
"      </a>",
"      dose range: 24 to 45",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"     </li>",
"     <li>",
"      Approximate weight 26 to 50 kg: 2 autoinjectors (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      dose range 0.08 to 0.13",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/8/16517?source=see_link\">",
"       pralidoxime",
"      </a>",
"      dose range: 24 to 45",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"     </li>",
"     <li>",
"      &gt;51 kg: 3 autoinjectors (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      dose range &le;0.11",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/8/16517?source=see_link\">",
"       pralidoxime",
"      </a>",
"      dose range: &le;35",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Supportive measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve agent poisoning requires the following measures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maintain a patent airway, and suction the endobronchial secretions.",
"     </li>",
"     <li>",
"      Ventilator assistance and supplementary oxygen as needed to treat respiratory failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link\">",
"       \"Overview of mechanical ventilation\"",
"      </a>",
"      .) If intubation is required, avoid using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"       succinylcholine",
"      </a>",
"      so as to prevent excess release of ACh [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Treatment of cardiovascular shock.",
"     </li>",
"     <li>",
"      Treatment of seizures. Nerve agents can cause persistent seizures that respond to benzodiazepine treatment.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       Diazepam",
"      </a>",
"      acts quickly and is found in most resuscitation kits in preference to other agents because it remains stable in liquid form for a long period of time. Diazepam 5 to 10 mg IV over the course of two minutes is given as initial therapy and repeated in 10 to 20 minutes. Up to 30 mg can be given in an eight-hour period. In a mass casualty situation, IV access may not be practical and diazepam can be administered IM to treat seizures. The initial dose of IM diazepam is 5 to 10 mg, and it may be repeated in 20 to 30 minutes if necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     TOXIC ASPHYXIANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydrogen cyanide (HCN) is a colorless liquid or gas that smells like bitter almonds and can cause death within eight minutes. Arsine is a colorless gas that smells like garlic and is sometimes mixed with the blister agent Lewisite.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Cyanide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Onset of symptoms after cyanide exposure is rapid and starts with mild irritation of the eyes, nose, and airways. The skin is flushed, and venous blood is red since capillary blood is unable to deposit oxygen in the tissues. Rapid breathing, headache, and tachycardia follow. Seen next are nausea and vomiting, confusion, muscular weakness, and trembling. In the severe stage of poisoning, the patient develops ARDS signs from the acute toxic lung injury, bluish skin due to oxygen deprivation, and finally respiratory and cardiac arrest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Arsine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial symptoms of arsine exposure are red eyes, garlic breath odor, and headache. Arsine combines with hemoglobin and produces a hemolytic anemia, which generates the classic arsine symptom triad of hemolysis, abdominal pain, and hematuria. Jaundice appears after 24 hours, and the skin has a coppery pigmentation thought to be due to methemoglobin. Death often results from renal failure. The hemoglobin-arsine complex cannot be dialyzed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Actions if exposed",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leave the exposure area at once, and move to fresh air. Cover your nose and mouth with a wet cloth. Emergency responders must wear gas masks with charcoal filters.",
"     </li>",
"     <li>",
"      Seek medical treatment. Specific antidotes are available for cyanide poisoning; however, no antidote is available for arsine exposure.",
"     </li>",
"     <li>",
"      Undergo decontamination. Remove clothing, which should be double bagged and sealed in plastic, in case liquid droplets of the agent are on the clothing. HCN gas rapidly dissipates in the open because it is lighter than air, thus decreasing the toxic risk. Shower with soap and water for about 15 minutes. Include rinsing the eyes with water for 5 to 10 minutes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Medical management",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Cyanide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Institute 100 percent oxygen at once. The standard cyanide poisoning antidote regimen consists of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/34/16933?source=see_link\">",
"     sodium nitrite",
"    </a>",
"    (or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"     amyl nitrite",
"    </a>",
"    ) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"     sodium thiosulfate",
"    </a>",
"    . Treatment may also be required for pulmonary failure, shock, acidosis, and seizures.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"       Amyl nitrite",
"      </a>",
"      ampules (if IV",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/34/16933?source=see_link\">",
"       sodium nitrite",
"      </a>",
"      is not available): If the patient is conscious (death usually occurs in about eight minutes with significant exposures), then antidotes are usually not needed. If an antidote is indeed indicated and intravenous nitrite (see below) is not available, then the nitrite ampule (0.3 mL) is broken and the vapors inhaled for about 30 seconds of each minute for three minutes. Then a new ampule is used and this cycle is repeated. Up to five ampules may be administered in this fashion. Nitrites form methemoglobin, which combines with cyanide to form cyanomethemoglobin. This reaction then frees cytochrome oxidase to resume its normal role in aerobic metabolism and thus promote patient recovery. Nitrites cause vasodilation and postural hypotension, so blood pressure must be carefully monitored. If IV access is obtained, IV sodium nitrite should be substituted for inhaled amyl nitrite.",
"     </li>",
"     <li>",
"      Intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/34/16933?source=see_link\">",
"       sodium nitrite",
"      </a>",
"      : This is the preferred nitrite agent if intravenous access is possible and practical. The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/16/14598?source=see_link\">",
"       cyanide antidote kit",
"      </a>",
"      contains 300 mg of sodium nitrite, which is infused over 5 to 15 minutes with careful monitoring of blood pressure. Half the dose (150 mg) may be repeated after 30 minutes.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"       Sodium thiosulfate",
"      </a>",
"      : The major mechanism for removing cyanide from the body is its enzymatic conversion to the relatively nontoxic thiocyanate complex. Sodium thiosulfate is a good source of sulfur donors to accelerate this reaction. Thiosulfate is given immediately after nitrite treatment. The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/16/14598?source=see_link\">",
"       cyanide antidote kit",
"      </a>",
"      contains two 50 mL vials (250",
"      <span class=\"nowrap\">",
"       mg/mL);",
"      </span>",
"      each provides 12.5 g of sodium thiosulfate. It is given by slow IV push. If there is poor progress, the nitrite plus thiosulfate regimen can be repeated in 30 minutes at one-half of the initial dosages.",
"     </li>",
"     <li>",
"      Dicobalt edetate (cobalt EDTA or Kelocyanor) is available in Europe and Australia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. This chelating agent is administered intravenously with a usual initial dose of 300 mg IV over one minute. The dose may be repeated twice at five minute intervals, for a total dose of 900 mg. Upon injection, the Cobalt EDTA compound is ionized, liberating cobalt cations. Each cobalt cation can combine with two cyanide anions, and the resultant stable compound is eliminated in the urine. The manufacturer recommends following each dose with 50 mL of 50 percent glucose, although that advice is controversial. Potentially fatal adverse events include hypotension, vomiting, hypertension, and cardiac arrhythmias. The drug should be used only in definite cases of cyanide poisoning.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/46/43749?source=see_link\">",
"       Hydroxocobalamin",
"      </a>",
"      is used in Europe for the treatment of cyanide toxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/16\">",
"       16",
"      </a>",
"      ]. The drug works by combining with cyanide to produce cyanocobalamin (vitamin B12). It appears to have a better adverse event profile than the traditional antidote of nitrite plus thiosulfate that was developed in the 1930s. Hydroxocobalamin is available in the US for treatment of B12 deficiency, but in much lower concentrations than would be needed to treat cyanide exposure. Doses for cyanide exposure are typically 2.5 to 5 g; administering 10 mL of a 40 percent solution IV over 20 minutes will deliver 4 g. Hydroxycobalamin does not produce methemoglobinemia nor the side effects associated with cobalt EDTA, and it may therefore have advantages for mass casualty treatment in a non-hospital setting so long as IV access can be achieved. Some authors believe that hydroxocobalamin should be stockpiled as the preferred treatment for a mass exposure in the US [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/16\">",
"       16",
"      </a>",
"      ]. If the medical system is overwhelmed with large numbers of cyanide casualties, then IV treatments are less feasible and treatment with ampules of inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/1/33813?source=see_link\">",
"       amyl nitrite",
"      </a>",
"      will be more practical.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Arsine",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no specific antidote for arsine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/2\">",
"     2",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/42/9893?source=see_link\">",
"     Dimercaprol",
"    </a>",
"    (BAL) provides no therapeutic benefit. Treatment is supportive and directed at the hemolysis and renal failure. Exchange transfusion has been recommended for patients with extensive hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/17\">",
"     17",
"    </a>",
"    ], and diuresis is recommended to avoid heme-pigment nephropathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43753?source=see_link&amp;anchor=H14#H14\">",
"     \"Extrinsic nonautoimmune hemolytic anemia due to drugs and toxins\", section on 'Arsine gas'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=see_link&amp;anchor=H25398978#H25398978\">",
"     \"Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)\", section on 'Prevention'",
"    </a>",
"    .) IV",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    and alkaline diuresis have been recommended based upon anecdotal reports. Dialysis is not useful in removing arsine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     PULMONARY IRRITANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosgene and chlorine are gases at room temperature. Phosgene is colorless and smells like newly mown hay. Chlorine is greenish-yellow and has a pungent smell. Ammonia is a colorless liquid and vapor that smells like the familiar household cleaning agent. These chemicals are in common industrial use and may be used by terrorists. At high pulmonary exposures, they can cause death within 10 minutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early symptoms from these agents are nose and throat irritation, cough, and chest pain. With lesser exposures, there may be a latent period of 24 hours, which is subsequently followed by shortness of breath and signs of pulmonary edema. Signs of acute lung injury that are seen within four hours of the exposure predict a low likelihood of survival.",
"   </p>",
"   <p>",
"    These agents burn and irritate the skin and the eyes. Exposure to ammonia is remarkable for a picture of deep burns and blisters that look like frostbite. Ammonia also causes severe long-term damage to the surface structures of the eye, leading to opaque corneas and cataracts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Actions if exposed",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leave the exposure area at once, and move to fresh air. Pulmonary agents are heavier than air, so do not lie down in the toxic area and do not go below ground level. Cover your nose and mouth with a wet cloth. Hold your breath if you can while escaping the toxic area. If you must breathe, take shallow breaths and as few as possible. Keep your eyes closed, if feasible, until away from the area of toxic release.",
"     </li>",
"     <li>",
"      Undergo decontamination. Remove clothing, begin a water shower, and in particular",
"      <strong>",
"       flush the eyes with water for about 10 minutes",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      Seek medical attention. Lung symptoms may be delayed for a few hours, but they can rapidly progress.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Medical management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient presents with acute respiratory distress, and the chest radiograph shows bilateral diffuse infiltrates [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/18\">",
"     18",
"    </a>",
"    ]. Bronchospasm is treated with bronchodilators and corticosteroids. Management of pulmonary failure with a ventilator may be required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9065?source=see_link\">",
"     \"Supportive care and oxygenation in acute respiratory distress syndrome\"",
"    </a>",
"    .) Bed rest is normally recommended until recovery is complete.",
"   </p>",
"   <p>",
"    Eyes should be treated with a mydriatic followed by a topical antibiotic [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     BLISTER AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blister agents include sulfur mustard and Lewisite. These are maiming agents, and their use during World War I produced over 125,000 casualties requiring medical evacuation and care. The death rate during World War I was no more than 4 percent, and most deaths associated with exposure to sulfur mustard resulted from complications such as infection [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/8\">",
"     8",
"    </a>",
"    ]. The agents' so-called \"radiomimetic\" effects, including leukopenia and damage to the mucosa of the gastrointestinal and respiratory tracts may also contribute to morbidity and mortality. No specific drug is available to counteract the effects of mustard gas on the skin, eyes, and lungs. Treatment is supportive and includes respiratory support, topical treatments, and pain relief. Although Lewisite is more difficult for terrorists to handle and transport, there is a topical antidote,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/42/9893?source=see_link\">",
"     dimercaprol",
"    </a>",
"    (BAL, British Anti Lewisite), which is effective if applied immediately to the skin and eyes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early respiratory symptoms are sore throat, cough, and hoarseness. Shortness of breath ensues in about 12 hours and, when it occurs, bacterial pneumonia on days three to four.",
"   </p>",
"   <p>",
"    Early skin symptoms include redness followed by pain and itching. Blisters form by 16 hours and reach a maximum by day three [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/19\">",
"     19",
"    </a>",
"    ]. Deep burns of the skin with slow healing and scarring may occur depending upon the level of exposure to the agent.",
"   </p>",
"   <p>",
"    Eyes are symptom free for the first 12 hours or so after sulfur mustard exposure. Then corneal symptoms, eye pain, and eyelid swelling occur. Blindness is uncommon, but damage to the ocular surface and cornea can be chronic and progressive [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/20\">",
"     20",
"    </a>",
"    ]. Corneal scarring can be repaired in many cases when healing is complete. With Lewisite exposure, skin and eye symptoms begin immediately. Overall, the blister agents are designed to incapacitate victims rather than kill them. The mortality rate is usually about 4 percent but depends upon the dose received and the baseline health status of the victim.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Actions if exposed",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leave the exposure area at once because seconds matter. Cover your nose and mouth with a wet cloth. Try not to inhale until away from the weapon release; take very shallow breaths if you must. Close your eyes as you escape, if possible, as blister agents can cause permanent eye damage within minutes. Blister agents are heavier than air, so do not lie down and do not go below ground level.",
"     </li>",
"     <li>",
"      Undergo decontamination. The severity of injury depends upon how quickly you decontaminate after leaving the area of exposure, so removal of contaminated clothing and copious water showers are imperative. Clothing should be removed carefully so as to avoid exposing the skin to any residues on the material; it is also important to avoid bringing contaminated materials into contact with medical personnel who are not wearing chemical-protective ensembles. Flush the eyes with water for 15 minutes. Seek medical attention for skin burns or respiratory burns at once. Clothing should be washed with ordinary household bleach solution (0.5 percent sodium hypochlorite), which will neutralize any persisting blister agent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Medical decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decontamination of blistering agents can be assisted with topical products [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. On July 31, 2003, the FDA approved a new chemical warfare decontamination lotion for use by military and civilian emergency services personnel. The product is called RSDL (Reactive Skin Decontamination Lotion), and it acts within seconds of being applied to the skin (",
"    <a class=\"external\" href=\"file://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130349.htm\">",
"     www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130349.htm",
"    </a>",
"    ). It neutralizes the toxicity of nerve and blister agents by breaking down these molecules. The lotion is specifically active against the liquid nerve agent VX and blister agents such as mustard and Lewisite. It may also be suitable for skin decontamination of biologic agents such as anthrax, and research results should soon be available to provide guidance.",
"   </p>",
"   <p>",
"    The lotion is packaged on a foam applicator inside a single use pouch. The lotion is applied within three minutes of contamination, and the non-toxic residue is washed away at a later time.",
"   </p>",
"   <p>",
"    RSDL was used in the 1991 Gulf War. Current research protocols are also testing the product for application to the entire body, including the eyes, nose, and mouth. The early use of RSDL will be by emergency response personnel, but one can anticipate wider labeled use of the product as experience is gained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Medical management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of sulfur mustard damage include extensive skin burns, pulmonary failure, eye damage, and later systemic effects such as infection and bone marrow suppression. These serious problems are treated with appropriate specialty care in a hospital setting. Studies are underway to assess the concept of immediate treatment with nonsteroidal anti-inflammatory drugs in the hope of decreasing post-exposure tissue damage.",
"   </p>",
"   <p>",
"    As mentioned above, Lewisite is a less available terrorist agent because of problems transporting the agent. There is a topical antidote,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/42/9893?source=see_link\">",
"     dimercaprol",
"    </a>",
"    , which can be applied to the skin to complex the Lewisite into a nontoxic product. Dimercaprol can also be formulated as a topical eye ointment. As a practical matter, however, these dimercaprol products are difficult to obtain and are usually not stocked by emergency response units or emergency departments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     OTHER RESOURCES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Reviews",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reviews are available that summarize chemical weapon threats and the most likely weapons to be used by terrorists [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/1,2,18\">",
"     1,2,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A book written by a retired Navy SEAL and CIA operations officer is adapted for civilian use from a manual of best practices used by the US armed forces [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/1\">",
"     1",
"    </a>",
"    ]. The book contains useful information regarding monitoring of the NBC terrorist threat and practical measures to protect individuals and families, if a weapon is released in the community.",
"   </p>",
"   <p>",
"    A book written by the medical director of New York City's Office of Emergency Management contains authoritative and well organized advice on how to cope with nuclear, biologic, and chemical terrorist events [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/2\">",
"     2",
"    </a>",
"    ]. This is a good book to keep both in the car and in the home in cities that are most at risk for terrorist attacks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h2\">",
"     Public health and law enforcement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Telephone numbers and website addresses are provided here for key agencies. Note that medical aspects of chemical terrorism and bioterrorism are undergoing rapid change and increased emphasis since the attacks of September 11, 2001. Therefore, it may be useful to consult the websites below for information on new drugs, dosages, and administration protocols.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Emergency Federal Hotline: Federal chemical and biological hotline (US Government Response Center): 800-424-8802",
"     </li>",
"     <li>",
"      CDC Medical Line: The physicians telephone line at CDC (Centers for Disease Control, Atlanta GA) is: (404) 639-3311. The CDC also has a very useful website (",
"      <a class=\"external\" href=\"file://www.bt.cdc.gov/\">",
"       www.bt.cdc.gov",
"      </a>",
"      ) that coordinates medical response activities of the US Government, and it is linked to several other useful sites. The site addresses both bioterrorism and chemical terrorism.",
"     </li>",
"     <li>",
"      Army Chemical Defense: The US Army Medical Research Institute of Chemical Defense (USAMRICD), Aberdeen PG, Maryland: (410) 436-2230 is an important source of current threat information and medical research information pertinent to terrorist chemical releases.",
"     </li>",
"     <li>",
"      Food and Drug Administration (FDA): The FDA has an excellent counterterrorism website that provides up to date labeling for drugs that are used as antidotes for chemical agents (",
"      <a class=\"external\" href=\"file://www.fda.gov/EmergencyPreparedness/default.htm\">",
"       www.fda.gov/EmergencyPreparedness/default.htm",
"      </a>",
"      ). Information on labeling for pediatric drug doses is also added as it is validated. The main telephone number for the drug center at the FDA is (301) 594-5400, in Rockville Maryland. The Chemical and Bioterrorism Office at the FDA is located in CDER (Center for Drug Evaluation and Research). The telephone number for the FDA counter-terrorism office is: (301) 827-7777.",
"     </li>",
"     <li>",
"      US Navy Resources: The Virtual Naval Hospital is a website devoted to military medicine and contains much information about chemical warfare agents and their medical management:",
"      <a class=\"external\" href=\"file://www.vnh.org/\">",
"       www.vnh.org",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Agency for Healthcare Research and Quality: A free comprehensive online reference is available to guide the care of children exposed to NBC terrorism [",
"      <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h3\">",
"     Public safety responders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the 1995 Tokyo subway attack, the US Marine Corps formed the Chemical Biological Incident Response Force (CBIRF) based near Washington DC [",
"    <a class=\"abstract\" href=\"UTD.htm?8/20/8521/abstract/22\">",
"     22",
"    </a>",
"    ]. At the invitation of local or state police, the CBIRF will deploy anywhere in the United States and provide capabilities for agent detection and identification, casualty search and rescue, personnel decontamination, and emergency care and stabilization of contaminated personnel. They can decontaminate 200 casualties per hour, and they have been trained and equipped to identify 120,000 toxic industrial chemicals. The CBIRF has unique expertise for saving lives in a contaminated environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6247929\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nerve agents, toxic asphyxiants, pulmonary irritants, and blistering agents are the major types of chemical weapons potentially available to terrorists. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Types of chemical agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The signature of a chemical weapon release is the sudden onset of symptoms within minutes, in the context of mass casualties (",
"      <a class=\"graphic graphic_table graphicRef62267 \" href=\"UTD.htm?9/9/9374\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis of chemical agent exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is inappropriate for responders to enter a situation until and unless they can do so without endangering themselves. Therefore, first response units organized to respond to chemical agent exposure must be equipped with appropriate protective clothing and equipment. It is also inappropriate to bring patients who are not decontaminated to first receiving facilities (hospitals and emergency departments). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Protection of responders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach and treatment vary according to the specific chemical agent. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Nerve agents'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Toxic asphyxiants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H33\">",
"       'Pulmonary irritants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H37\">",
"       'Blister agents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29528769\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Couch, D. United States Armed Forces Nuclear, Biological and Chemical Survival Manual, Basic Books, New York 2003.",
"    </li>",
"    <li>",
"     Acquista, A. The Survival Guide: what to do in a biological, chemical or nuclear emergency, Random House, New York 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/3\">",
"      Noort D, Benschop HP, Black RM. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol 2002; 184:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/4\">",
"      Reutter S. Hazards of chemical weapons release during war: new perspectives. Environ Health Perspect 1999; 107:985.",
"     </a>",
"    </li>",
"    <li>",
"     Taylor, P. Anticholinesterase Agents. In: The Pharmacological Basis of Therapeutics, 10th edition, Hardman, JG, Limbird, LE (Eds), McGraw-Hill, New York 2001. p.175.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/6\">",
"      Wormser U. Toxicology of mustard gas. Trends Pharmacol Sci 1991; 12:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/7\">",
"      Centers for Disease Control and Prevention (CDC). Recognition of illness associated with exposure to chemical agents--United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/8\">",
"      Devereaux A, Amundson DE, Parrish JS, Lazarus AA. Vesicants and nerve agents in chemical warfare. Decontamination and treatment strategies for a changed world. Postgrad Med 2002; 112:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/9\">",
"      Munro NB, Watson AP, Ambrose KR, Griffin GD. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ Health Perspect 1990; 89:205.",
"     </a>",
"    </li>",
"    <li>",
"     United States Food and Drug Administration www.fda.gov/EmergencyPreparedness/default.htm (Accessed on May 07, 2005).",
"    </li>",
"    <li>",
"     Protopam&reg; Injection Supplement S-024 DRAFT Package Insert. Food and Drug Administration, United States of America. file://www.accessdata.fda.gov/drugsatfda_docs/label/2002/14134s24lbl.pdf (Accessed on September 20, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/12\">",
"      Henretig FM, Cieslak TJ, Eitzen EM Jr. Biological and chemical terrorism. J Pediatr 2002; 141:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/13\">",
"      Bozeman WP, Dilbero D, Schauben JL. Biologic and chemical weapons of mass destruction. Emerg Med Clin North Am 2002; 20:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/14\">",
"      Beasley DM, Glass WI. Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med (Lond) 1998; 48:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/15\">",
"      Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/16\">",
"      Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med 2001; 37:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/17\">",
"      Danielson C, Houseworth J, Skipworth E, et al. Arsine toxicity treated with red blood cell and plasma exchanges. Transfusion 2006; 46:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/18\">",
"      Greenfield RA, Brown BR, Hutchins JB, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002; 323:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/19\">",
"      Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991; 127:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/20\">",
"      Javadi MA, Yazdani S, Sajjadi H, et al. Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 2005; 112:617.",
"     </a>",
"    </li>",
"    <li>",
"     Pediatric terrorism and disaster preparedness: a resource for pediatricians. file://www.ahrq.gov/RESEARCH/PEDPREP/ (Accessed on September 21, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/20/8521/abstract/22\">",
"      Gourley, SR. US Marine Corps Chemical Biological Incident Response Force. Military Medical Technology 2003; 7:6.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2020 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-29E1B55F6D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8521=[""].join("\n");
var outline_f8_20_8521=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6247929\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TYPES OF CHEMICAL AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nerve agents (cholinesterase inhibitors)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Toxic asphyxiants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pulmonary irritants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Blister agents (vesicants)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS OF CHEMICAL AGENT EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neurologic symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pulmonary symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Skin and eye burns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Rash",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Gastrointestinal bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PROTECTION OF RESPONDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      NERVE AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Actions if exposed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Medical decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Medical management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Atropine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Pralidoxime",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Supportive measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      TOXIC ASPHYXIANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Cyanide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Arsine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Actions if exposed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Medical management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Cyanide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Arsine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      PULMONARY IRRITANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Actions if exposed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Medical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      BLISTER AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Actions if exposed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Medical decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Medical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      OTHER RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Reviews",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      Public health and law enforcement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      - Public safety responders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6247929\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29528769\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/2020\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/2020|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/9/9374\" title=\"table 1\">",
"      Major chemical weapon exposures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7224?source=related_link\">",
"      Clinical manifestations and diagnosis of anthrax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/18/7466?source=related_link\">",
"      Cyanide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24265?source=related_link\">",
"      Differential diagnosis of microbial foodborne disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40121?source=related_link\">",
"      Diseases potentially acquired by travel to sub-Saharan Africa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43753?source=related_link\">",
"      Extrinsic nonautoimmune hemolytic anemia due to drugs and toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=related_link\">",
"      Identifying and managing casualties of biological terrorism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/25/33176?source=related_link\">",
"      Organophosphate and carbamate poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=related_link\">",
"      Overview of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=related_link\">",
"      Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/54/9065?source=related_link\">",
"      Supportive care and oxygenation in acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/61/35797?source=related_link\">",
"      The epidemiology, pathogenesis, and clinical manifestations of smallpox",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_20_8522="Pityrosporum folliculitis 2";
var content_f8_20_8522=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86998%7EDERM%2F86997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86998%7EDERM%2F86997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pityrosporum folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pinpoint&nbsp;follicular papules and pustules are characteristic of Pityrosporum folliculitis. The eruption most often involves the upper trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pityrosporum folliculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Follicular papules and pustules on the upper back of a patient with Pityrosporum folliculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8522=[""].join("\n");
var outline_f8_20_8522=null;
var title_f8_20_8523="Factors contrib CRS";
var content_f8_20_8523=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F74779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F74779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Disorders that may exacerbate and/or contribute to CRS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Allergic rhinitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic exposure to environmental irritants or ciliostatic substances (eg, tobacco smoke)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunodeficiency states (especially defects in antibody production or function)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Defects in mucociliary clearance (eg, cystic fibrosis and primary ciliary dyskinesia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recurrent viral upper respiratory tract infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic disorders (eg, granulomatosis with polyangiitis (Wegener's), Churg-Strauss vasculitis, sarcoidosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anatomic abnormalities predisposing to sinus obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iatrogenic (due to complications of repeated sinus surgery)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8523=[""].join("\n");
var outline_f8_20_8523=null;
var title_f8_20_8524="Complications associated with multiple gestation";
var content_f8_20_8524=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Problems occurring more often in multiple gestations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Maternal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early or late fetal loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preeclampsia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gestational diabetes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydramnios",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antepartum bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prolonged hospitalization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preterm birth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cesarean delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postpartum bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parental stress (psychological, economic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Fetal or neonatal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Preterm delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cerebral palsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Intraventricular hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Retinopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sepsis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Respiratory problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Necrotizing enterocolitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hyperbilirubinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patent ductus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hypoglycemia, hypocalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Prolonged hospitalization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Longterm disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High medical costs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perinatal mortality",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Adamson, D, Baker, V. Fertil Steril 2004; 81:517.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8524=[""].join("\n");
var outline_f8_20_8524=null;
var title_f8_20_8525="Energy requirements children";
var content_f8_20_8525=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Caloric intake by age, gender, and activity level",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"3\">",
"        Age (y)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\" rowspan=\"1\">",
"        Activity level",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"2\" rowspan=\"1\">",
"        Males",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\" rowspan=\"1\">",
"        Females",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Sedentary",
"       </td>",
"       <td class=\"subtitle3\">",
"        Active",
"       </td>",
"       <td class=\"subtitle3\">",
"        Sedentary",
"       </td>",
"       <td class=\"subtitle3\">",
"        Active",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        1200",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        2200",
"       </td>",
"       <td>",
"        1400",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2200",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        2200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        2600",
"       </td>",
"       <td>",
"        1600",
"       </td>",
"       <td>",
"        2200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        2800",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        2200",
"       </td>",
"       <td>",
"        3000",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"       <td>",
"        3200",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"       <td>",
"        3200",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"       <td>",
"        3200",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2400",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Sedentary: less than 30 minutes daily of additional moderate physical activity; Active: 60 minutes or more daily of additional moderate physical activity.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8525=[""].join("\n");
var outline_f8_20_8525=null;
var title_f8_20_8526="Angiographic variables associated with reocclusion";
var content_f8_20_8526=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angiographic variables associated with reocclusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 271px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The TIMI 4 trial performed angiography 90 minutes after successful thrombolysis and found that factors associated with a higher rate of infarct-related coronary artery reocclusion were lesion ulceration (p = 0.009), presence of collateral (p = 0.03), lesion eccentricity (p = 0.06), and lesions with thrombus (p = 0.06).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gibson CM, Cannon CP, Piana RN, et al. J Am Coll Cardiol 1995; 25:582.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8526=[""].join("\n");
var outline_f8_20_8526=null;
var title_f8_20_8527="Lateral malleolus definition";
var content_f8_20_8527=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral malleolus definition",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 298px; height: 480px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is no single, widely accepted definition of the anatomic margins of the lateral malleolus. For the purpose of this review, the lateral malleolus refers to the distal part of the fibula that articulates with the talus and distal tibia. Lateral malleolar fractures lie between the distal tip of the fibula (inferior yellow line) and the most proximal portion of the fibula that lies directly adjacent to the tibia in the tibial groove (superior yellow line).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrice Eiff, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_20_8527=[""].join("\n");
var outline_f8_20_8527=null;
       